Acrofacial Dysostosis Cincinnati Type

Mendelian MONDO:0014651 Pathograph 78 Show in embeddings browser Acrofacial dysostosis Mandibulofacial dysostosis Ribosomopathy

Acrofacial dysostosis Cincinnati type is a POLR1A-related developmental disorder initially recognized by mandibulofacial dysostosis with variable limb abnormalities. Heterozygous variants can also be associated with developmental impairment, epilepsy and congenital cardiac anomalies, while some individuals have mild craniofacial findings and normal development. Both de novo and inherited variants occur. POLR1A encodes the largest catalytic subunit of RNA polymerase I. Experimental effects vary by allele: some variants decrease ribosomal RNA transcription, some increase it, and others have no detectable effect in the tested assays. Reduced transcription and ribosomal stress cause early neural crest or neuroepithelial cell loss in animal models; later cartilage development also requires Polr1a. These model mechanisms do not establish a uniform biochemical defect or a complete explanation for every human phenotype.

Ask OpenScientist

Ask a research question about Acrofacial Dysostosis Cincinnati Type. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🔗

Mappings

MONDO

MONDO:0014651 acrofacial dysostosis Cincinnati type

👪

Inheritance

Autosomal dominant HP:0000006

Heterozygous pathogenic POLR1A variants can arise de novo or be transmitted. Inherited variants have been observed in mildly affected or apparently unaffected parents; variant-specific uncertainty and subtle parental findings prevent a penetrance estimate.

Autosomal dominant inheritance

Show evidence (2 references)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1."

The founding human cases establish heterozygous variants.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"ﬁve individuals (1, 2, 9, 10, and 12) inherited their variant from a reportedly unaffected parent."

The study documents transmission from reportedly unaffected parents, with possible subtle findings and uncertain penetrance.

◈

Mechanistic Hypotheses

Reduced Pol I transcription and early neural crest depletion

pol1_nucleolar_stress_ncc_apoptosis CANONICAL

Experimental Polr1a loss reduces precursor rRNA and ribosome production. Ribosomal protein-Mdm2 interactions, p53 pathway activity and apoptosis support a stress-mediated depletion mechanism in early developmental models. The molecular interaction assays were performed in mouse embryonic fibroblasts, and the developmental phenotypes in fish and mouse embryos. Human allele effects are heterogeneous; this model describes the reduced-function branch rather than every POLR1A variant.

Pathograph links

Heterozygous POLR1A Variants -> Abnormal Pol I Condensate Formation INDIRECT UNKNOWN INTERMEDIATES p.Glu593Gln alters polymerase localization in an overexpression model; physiological heterozygous dosage in patient tissue was not tested.

Heterozygous POLR1A Variants -> Reduced Pol I rRNA Transcription INDIRECT UNKNOWN INTERMEDIATES Some alleles, including p.Arg393His and p.Glu593Gln, reduce rRNA synthesis in the tested cell context.

Abnormal Pol I Condensate Formation -> Reduced Pol I rRNA Transcription INDIRECT UNKNOWN INTERMEDIATES Dominant-negative interference with productive transcription is supported in the engineered assay; chromatin-binding competition is an inferred molecular explanation.

Reduced Pol I rRNA Transcription -> Reduced Ribosome Availability INDIRECT UNKNOWN INTERMEDIATES Lower precursor-rRNA output is linked to reduced monosome and polysome abundance in the fish model.

Reduced Pol I rRNA Transcription -> Increased RPL5 and RPL11 Binding to MDM2 INDIRECT UNKNOWN INTERMEDIATES A proposed imbalance between reduced rRNA and unchanged ribosomal proteins alters Mdm2 interactions in knockout fibroblasts; free-protein stoichiometry was not directly established in human neural crest.

Reduced Ribosome Availability -> Reduced Protein Translation INDIRECT UNKNOWN INTERMEDIATES Reduced ribosome profiles accompany lower protein synthesis in the fish model, consistent with limited translational capacity.

Increased RPL5 and RPL11 Binding to MDM2 -> Reduced MDM2 Binding to p53 INDIRECT UNKNOWN INTERMEDIATES Increased ribosomal-protein binding accompanies reduced Mdm2-p53 interaction. Competition is a supported interpretation of the co-immunoprecipitation pattern.

Reduced MDM2 Binding to p53 -> Increased p53 Pathway Activity INDIRECT UNKNOWN INTERMEDIATES Reduced Mdm2 association provides a proposed stabilization mechanism that complements developmental p53-pathway observations.

Increased p53 Pathway Activity -> Early Neuroepithelial and Neural Crest Apoptosis INDIRECT UNKNOWN INTERMEDIATES Genetic tp53 loss of function suppresses early fish neuroepithelial apoptosis, supporting a causal early component without preventing later cell death.

Early Neuroepithelial and Neural Crest Apoptosis -> Depletion of Cranial Skeletal Precursors INDIRECT UNKNOWN INTERMEDIATES Early death reduces the population available to populate the pharyngeal arches; fish rescue restores early colonization, arguing against an intrinsic migration failure.

Depletion of Cranial Skeletal Precursors -> Mandibulofacial Dysostosis INDIRECT UNKNOWN INTERMEDIATES Developmental models support reduced cranial precursor supply as a contributor to human craniofacial malformations, with unmeasured tissue and allele-specific intermediates.

Depletion of Cranial Skeletal Precursors -> Micrognathia INDIRECT UNKNOWN INTERMEDIATES Reduced precursor supply can contribute to mandibular hypoplasia; the experimental-to-human bridge is indirect.

Depletion of Cranial Skeletal Precursors -> Malar Hypoplasia INDIRECT UNKNOWN INTERMEDIATES Experimental depletion of neural-crest-derived skeletal precursors provides a plausible route to zygomatic hypoplasia in the human spectrum. The human allele-specific mediator has not been directly measured.

Residual developmental defects after p53 inhibition

pol1_p53_independent_arm EMERGING

Genetic tp53 inhibition incompletely rescues polr1a-mutant zebrafish cartilage and does not restore rRNA transcription or neural crest proliferation. Additional growth and developmental requirements remain, although later apoptosis also recurs. The residual defects do not establish complete apoptosis independence.

Pathograph links

Reduced Pol I rRNA Transcription -> Reduced Neural Crest Cell Proliferation INDIRECT UNKNOWN INTERMEDIATES The fish model retains a proliferation deficit when early tp53-mediated apoptosis is suppressed; the intervening mechanism is unresolved.

Reduced Neural Crest Cell Proliferation -> Depletion of Cranial Skeletal Precursors INDIRECT UNKNOWN INTERMEDIATES Insufficient expansion may contribute to the residual cranial precursor deficit after transient protection from apoptosis.

Depletion of Cranial Skeletal Precursors -> Micrognathia INDIRECT UNKNOWN INTERMEDIATES Reduced precursor supply can contribute to mandibular hypoplasia; the experimental-to-human bridge is indirect.

Later Polr1a requirement for craniofacial skeletal development

pol1_late_skeletogenesis EMERGING

Ubiquitous temporal Polr1a deletion after early neural crest migration reduces mandibular SOX9 and skeletal condensations. This establishes a later experimental requirement without distinguishing altered differentiation, proliferation or survival; p53 was not perturbed in that experiment.

Pathograph links

Heterozygous POLR1A Variants -> Impaired Later Craniofacial Skeletogenesis INDIRECT UNKNOWN INTERMEDIATES Temporal mouse Polr1a loss establishes a later developmental requirement; the bridge from heterozygous human variants remains indirect.

Impaired Later Craniofacial Skeletogenesis -> Reduced Craniofacial Skeletal Condensations INDIRECT UNKNOWN INTERMEDIATES The temporal knockout links Polr1a loss to smaller and discontinuous skeletal structures, without isolating the intervening cellular mechanism.

Reduced Craniofacial Skeletal Condensations -> Micrognathia INDIRECT UNKNOWN INTERMEDIATES Reduced mandibular skeletogenesis and discontinuous Meckel cartilage in the temporal mouse knockout provide a plausible experimental route to mandibular hypoplasia. This does not demonstrate the mediator in heterozygous human patients.

Discussions and Knowledge Gaps

How do allele-specific transcription changes relate to clinical severity?

polr1a_allelic_heterogeneity

The 2023 cell assay separates reduced, increased and unchanged transcription. Neither direction alone explains the clinical spectrum. The p.Met496Ile structural modeling in 2025 is computational and does not override the measured mild increase in the 2023 assay. The 2020 p.Glu593Gln experiment supports a dominant-negative mechanism under inducible expression, not a universal mechanism for all variants.

Show evidence (3 references)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type"

Engineered HCT116 cells show lower rRNA synthesis for these two alleles.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del."

These alleles increase nascent nucleolar RNA in the engineered cell assay.

PMID:41010008 SUPPORT DIRECT PRIMARY RESULT Computational

"Structural modeling of the Met496Ile variant suggested disruption of DNA binding and polymerase activity"

The proposed interaction defect is computational; no direct activity experiment was performed in this report.

What explains the limb abnormalities?

polr1a_limb_mechanism

The developmental neural crest findings explain a craniofacial route. Limb skeletal abnormalities require a separate mechanism that remains unresolved; they are not modeled as a direct consequence of cranial neural crest depletion.

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT BACKGROUND Other

"The specific mechanism underpinning femoral bowing, metaphyseal flaring, and delayed epiphyseal ossification in individual 1A1 is not yet understood."

The founding paper explicitly leaves the limb mechanism unresolved.

Does later Polr1a loss cause a distinct developmental defect?

polr1a_later_development

Temporal ubiquitous knockout supports a later requirement for skeletal development, but its cell-state proportions and morphology do not discriminate fate selection from altered survival or proliferation. Separate NHP2 and TSR3 perturbations in engineered iPSCs and mice are not proven mediators of human POLR1A disease. The 2026 correction concerned author names and did not alter experimental results.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development."

Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.

Which features are attributable to POLR1A in the expanded cohort?

polr1a_cohort_attribution

The 2023 series includes related individuals and uncertain variants. Individual 13 also carries a de novo ATP1A1 variant; p.Pro1638Leu in individual 18 lacks supporting transcription or mouse phenotypes. Cohort counts therefore describe the reported series rather than confirmed feature frequencies. Craniosynostosis and hearing impairment are documented and are not valid exclusion criteria.

Show evidence (2 references)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individ- uals were included if they had a heterozygous variant in POLR1A interpreted as being of uncertain signiﬁcance, likely pathogenic, or pathogenic"

Ascertainment explicitly included variants of uncertain significance.

PMID:41010008 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Furthermore, our patient was reported, unbeknownst to us, with limited clinical, genetic, and protein data or analysis by Smallwood et al."

The 2025 report explicitly identifies its overlap with individual 8 of the 2023 cohort.

⚙

Pathophysiology

Heterozygous POLR1A Variants

Germline heterozygous variants are associated with the human disorder. Missense, truncating and in-frame alleles have diverse experimental effects; neither uniform haploinsufficiency nor universal loss of function is established.

Later Polr1a requirement for craniofacial skeletal development Reduced Pol I transcription and early neural crest depletion

POLR1A hgnc:17264

Genetic context variant_origin: GERMLINE zygosity: HETEROZYGOUS

De novo or inherited heterozygous POLR1A variants; functional consequences are allele-specific.

Animal models

Forebrain conditional Polr1a loss and C1559F Mouse perturbs Orthologous Polr1a manipulation tests the developmental requirement in forebrain progenitors.

Polr1a germline variant knock-in mice Mouse perturbs Knock-in models compare the effects of specific orthologous variants.

Downstream

Abnormal Pol I Condensate Formation p.Glu593Gln alters polymerase localization in an overexpression model; physiological heterozygous dosage in patient tissue was not tested.

Reduced Pol I rRNA Transcription Some alleles, including p.Arg393His and p.Glu593Gln, reduce rRNA synthesis in the tested cell context.

Increased Pol I rRNA Transcription Other alleles increase nascent nucleolar RNA in the engineered cell assay.

Impaired Later Craniofacial Skeletogenesis Temporal mouse Polr1a loss establishes a later developmental requirement; the bridge from heterozygous human variants remains indirect.

Cleft Palate The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Hypertelorism The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Downslanted Palpebral Fissures The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Eyelid Coloboma The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Anotia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Microtia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Conductive Hearing Impairment The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Sensorineural Hearing Impairment The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Choanal Atresia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Microcephaly The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Metopic Craniosynostosis The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Acalvaria The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Short Stature The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Femoral Bowing The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Flared Metaphyses The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Acetabular Dysplasia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Delayed Femoral Epiphyseal Ossification The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Brachydactyly The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Radial Aplasia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Preaxial Hand Polydactyly The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Clubfoot The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Atrial Septal Defect The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Ventricular Septal Defect The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Patent Ductus Arteriosus The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Hypertrophic Cardiomyopathy The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Hydrocephalus The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Syringomyelia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Hypotonia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Global Developmental Delay The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Seizure The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Epileptic Encephalopathy The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Vocal Cord Paralysis The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Failure to Thrive The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Cryptorchidism The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Hydronephrosis The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Sleep Apnea The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Ptosis The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Cleft Lip The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Lower Limb Spasticity The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Dystonia The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Strabismus The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Low-set Ears The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1."

Human cases establish the heterozygous POLR1A association.

Abnormal Pol I Condensate Formation

Inducible p.Glu593Gln POLR1A in HeLa cells produces abnormal nucleolar condensates containing mutant and wild-type polymerase. Single-molecule tracking supports stable mutant association and impaired productive wild-type binding as a dominant-negative model. Expression was approximately twice the endogenous level; this is not a measurement in patient neural crest cells.

Reduced Pol I transcription and early neural crest depletion

nucleolus GO:0005730

Experimental models

Inducible POLR1A p.Glu593Gln in HeLa cells CELL LINE Mutant and wild-type polymerase relocalize to abnormal condensates.

Downstream

Reduced Pol I rRNA Transcription Dominant-negative interference with productive transcription is supported in the engineered assay; chromatin-binding competition is an inferred molecular explanation.

Show evidence (1 reference)

PMID:33055158 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Not only the mutant but also the WT Pol I was localized to the condensates (HaloTag-WT RPA194; Fig. 4A), suggesting that mutant Pol I compromised the stable Pol I cluster."

Mutant and wild-type polymerase relocalize in an inducible HeLa overexpression experiment.

Reduced Pol I rRNA Transcription

Reduced precursor-rRNA output occurs in polr1a-mutant zebrafish and Polr1a-deleted mouse neural crest, and in cells expressing selected human variants. Spacer-region qPCR is a transcription proxy. Mature rRNA abundance can initially remain unchanged; this branch does not apply to every allele.

Reduced Pol I transcription and early neural crest depletion Residual developmental defects after p53 inhibition

transcription by RNA polymerase I GO:0006360 ↓ DECREASED

nucleolus GO:0005730

Experimental models

Human POLR1A variant replacement in HCT116 cells CELL LINE p.Arg393His and p.Glu593Gln reduce nucleolar RNA synthesis.

Inducible POLR1A p.Glu593Gln in HeLa cells CELL LINE 47S precursor rRNA decreases markedly after mutant induction.

Animal models

polr1a mutant zebrafish with genetic tp53 suppression Zebrafish measures Precursor-rRNA spacer abundance falls in the mutant and is not restored by tp53 inhibition.

Early neural crest-restricted Polr1a deletion in mouse Mouse measures Sorted neural crest cells have reduced precursor-rRNA signal.

Downstream

Reduced Ribosome Availability Lower precursor-rRNA output is linked to reduced monosome and polysome abundance in the fish model.

Increased RPL5 and RPL11 Binding to MDM2 A proposed imbalance between reduced rRNA and unchanged ribosomal proteins alters Mdm2 interactions in knockout fibroblasts; free-protein stoichiometry was not directly established in human neural crest.

Reduced Neural Crest Cell Proliferation The fish model retains a proliferation deficit when early tp53-mediated apoptosis is suppressed; the intervening mechanism is unresolved.

Show evidence (2 references)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type"

Engineered HCT116 cells show lower rRNA synthesis for these two alleles.

Increased Pol I rRNA Transcription

Nascent nucleolar RNA increases with p.Asp59Val, p.Glu1330del and p.Cys1562Phe in engineered HCT116 cells after endogenous POLR1A depletion. p.Met496Ile and p.Val1241Ile show milder increases. These assays establish neither increased ribosome output in patients nor a causal link to a particular clinical feature.

transcription by RNA polymerase I GO:0006360 ↑ INCREASED

Experimental models

Human POLR1A variant replacement in HCT116 cells CELL LINE p.Asp59Val, p.Glu1330del and p.Cys1562Phe increase the RNA signal; two other alleles increase it mildly.

Show evidence (1 reference)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del."

These alleles increase nascent nucleolar RNA in the engineered cell assay.

Reduced Ribosome Availability

Monosome and polysome profiles are reduced in mutant zebrafish. This is a separate measured consequence from precursor-rRNA abundance and protein translation.

Reduced Pol I transcription and early neural crest depletion

Animal models

polr1a mutant zebrafish with genetic tp53 suppression Zebrafish measures Monosome and polysome profiles decrease.

Downstream

Reduced Protein Translation Reduced ribosome profiles accompany lower protein synthesis in the fish model, consistent with limited translational capacity.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

Reduced Protein Translation

The zebrafish mutant has impaired protein translation. Mouse neural crest knockout studies also show reduced total protein by silver staining, which does not by itself measure translation rate.

translation GO:0006412 ↓ DECREASED

Animal models

polr1a mutant zebrafish with genetic tp53 suppression Zebrafish measures Radiolabeled methionine incorporation measures reduced protein synthesis.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

Increased RPL5 and RPL11 Binding to MDM2

Co-immunoprecipitation in tamoxifen-deleted mouse embryonic fibroblasts shows increased binding of Rpl5 and Rpl11 to Mdm2 without a measured increase in their total abundance. Transfer of this interaction mechanism to patient cranial progenitors is inferred.

Reduced Pol I transcription and early neural crest depletion

Experimental models

Tamoxifen-induced Polr1a deletion in mouse embryonic fibroblasts PRIMARY CELL CULTURE Rpl5 and Rpl11 binding to Mdm2 increases.

Downstream

Reduced MDM2 Binding to p53 Increased ribosomal-protein binding accompanies reduced Mdm2-p53 interaction. Competition is a supported interpretation of the co-immunoprecipitation pattern.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls"

Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.

Reduced MDM2 Binding to p53

Mdm2-p53 co-immunoprecipitation decreases in the knockout fibroblast assay. Reduced degradation is the proposed consequence; the interaction experiment is not a patient-tissue degradation-rate measurement.

Reduced Pol I transcription and early neural crest depletion

Experimental models

Tamoxifen-induced Polr1a deletion in mouse embryonic fibroblasts PRIMARY CELL CULTURE Mdm2-p53 co-immunoprecipitation decreases.

Downstream

Increased p53 Pathway Activity Reduced Mdm2 association provides a proposed stabilization mechanism that complements developmental p53-pathway observations.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls"

Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.

Increased p53 Pathway Activity

Polr1a loss activates the p53 response in developmental models. Fish p53 assays and genetic inhibition support involvement. In mouse neural crest, p21 rises even though p53 protein elevation is not significant at the sampled stage.

Reduced Pol I transcription and early neural crest depletion

Downstream

Early Neuroepithelial and Neural Crest Apoptosis Genetic tp53 loss of function suppresses early fish neuroepithelial apoptosis, supporting a causal early component without preventing later cell death.

Show evidence (2 references)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT Model Organism

"examination of cell-cycle inhibitor and p53 target gene p21 by qPCR demonstrated a significant increase in the NCCs of Polr1aNKO/NKO mutants"

A downstream p53 target increased in mutant neural crest cells; the p53 protein difference itself was not significant at this stage.

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype."

Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.

Early Neuroepithelial and Neural Crest Apoptosis

Early neuroepithelial apoptosis in mutant fish reduces the source of cranial neural crest cells; mouse neural crest-restricted Polr1a loss also causes apoptosis. In fish, tp53 inhibition suppresses apoptosis at 24–48 hours but TUNEL labeling returns by 60 hours. Early protection is not permanent abolition of cell death.

Reduced Pol I transcription and early neural crest depletion

neural crest cell CL:0011012 neuroepithelial cell CL:0000710

apoptotic process GO:0006915 ↑ INCREASED

Animal models

polr1a mutant zebrafish with genetic tp53 suppression Zebrafish rescues tp53 M214K suppresses early neuroepithelial TUNEL labeling.

Early neural crest-restricted Polr1a deletion in mouse Mouse rescues Neural crest loss contributes to craniofacial hypoplasia; p53 inhibition improves early arch development.

Downstream

Depletion of Cranial Skeletal Precursors Early death reduces the population available to populate the pharyngeal arches; fish rescue restores early colonization, arguing against an intrinsic migration failure.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype."

Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.

Reduced Neural Crest Cell Proliferation

In the fish double-mutant experiment, arch neural crest proliferation remains about half of control at 36 hours despite tp53 inhibition. The earlier 24-hour reduction is not significant. This is a proliferation defect rather than proof of an intrinsic migration defect.

Residual developmental defects after p53 inhibition

neural crest cell CL:0011012

Animal models

polr1a mutant zebrafish with genetic tp53 suppression Zebrafish measures Arch neural crest proliferation remains reduced at 36 hours in both mutant backgrounds.

Downstream

Depletion of Cranial Skeletal Precursors Insufficient expansion may contribute to the residual cranial precursor deficit after transient protection from apoptosis.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The percentage of proliferating neural crest cells in 36 hpf control embryos was 13.24% (n= 5), although inpolr1a–/–(n= 6) andpolr1a–/–;tp53–/–(n= 6) embryos it was 6.00% and 6.38%, respectively."

The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.

Depletion of Cranial Skeletal Precursors

Loss and insufficient expansion of cranial neural crest-derived precursors reduce the population that forms craniofacial cartilage and bone. This mechanism does not directly explain mesoderm-derived limb malformations.

Reduced Pol I transcription and early neural crest depletion Residual developmental defects after p53 inhibition

neural crest cell CL:0011012

Downstream

Mandibulofacial Dysostosis Developmental models support reduced cranial precursor supply as a contributor to human craniofacial malformations, with unmeasured tissue and allele-specific intermediates.

Micrognathia Reduced precursor supply can contribute to mandibular hypoplasia; the experimental-to-human bridge is indirect.

Malar Hypoplasia Experimental depletion of neural-crest-derived skeletal precursors provides a plausible route to zygomatic hypoplasia in the human spectrum. The human allele-specific mediator has not been directly measured.

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Model Organism

"resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies."

The fish model links early cell death with a smaller neural crest population.

Impaired Later Craniofacial Skeletogenesis

Ubiquitous R26-CreERT2 deletion of Polr1a induced at E9.0–9.5 and assessed at E12.5 reduces SOX9 signal and disrupts cartilage development. The timing spans late migration and post-migration. Relative transcriptomic cell proportions do not distinguish fate change from differential proliferation or survival.

Later Polr1a requirement for craniofacial skeletal development

Animal models

Late migratory and post-migratory temporal Polr1a deletion Mouse measures SOX9 signal and cartilage development decrease after temporal deletion.

Downstream

Reduced Craniofacial Skeletal Condensations The temporal knockout links Polr1a loss to smaller and discontinuous skeletal structures, without isolating the intervening cellular mechanism.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development."

Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.

Reduced Craniofacial Skeletal Condensations

Temporal Polr1a deletion reduces facial mesenchymal condensations and disrupts Meckel cartilage. Trigeminal ganglion volume is comparatively preserved. These observations do not establish normal neural function or absolute expansion of neuroglial cells.

Later Polr1a requirement for craniofacial skeletal development

Animal models

Late migratory and post-migratory temporal Polr1a deletion Mouse measures Facial condensations decrease and Meckel cartilage becomes discontinuous.

Downstream

Micrognathia Reduced mandibular skeletogenesis and discontinuous Meckel cartilage in the temporal mouse knockout provide a plausible experimental route to mandibular hypoplasia. This does not demonstrate the mediator in heterozygous human patients.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected"

MicroCT identifies a preferential skeletal-condensation phenotype in the temporal mouse model.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Cardiovascular 4

Atrial Septal Defect HP:0001631

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis."

An atrial septal defect was reported in the p.Met496Ile infant.

Ventricular Septal Defect HP:0001629

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She had congenital unilateral vocal cord paralysis, short stature (147.5 cm), small HC (< 3rd) ptosis, subaortic ventricular septal defect, myopia, and hypotonia."

Ventricular septal defects are documented in several individuals in the expanded series.

Patent Ductus Arteriosus HP:0001643

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Other | short stature | patent ductus arteriosus |"

Patent ductus arteriosus was recorded in the second founding case and in later reports.

Hypertrophic Cardiomyopathy HP:0001639

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She was found to have hypertrophic cardiomyopathy and elevated lactate."

Hypertrophic cardiomyopathy was documented in the severely affected infant with a de novo early frameshift; this is an individual observation.

Ear 5

Anotia HP:0009892

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Bilateral anotia and severe conductive hearing loss were present. At birth, head circumference was 33 cm (−1.7 SDs), length was 43 cm (−4 SDs), and weight was 2.4 kg (−2.5 SDs)."

Bilateral absence of external ears was documented in the severely affected index infant.

Microtia HP:0008551

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"down-slanting palpebral fissures, malar flattening, unilateral microtia, micrognathia (mild)"

Unilateral microtia was recorded in the adult founding case.

Conductive Hearing Impairment HP:0000405

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Bilateral anotia and severe conductive hearing loss were present. At birth, head circumference was 33 cm (−1.7 SDs), length was 43 cm (−4 SDs), and weight was 2.4 kg (−2.5 SDs)."

Severe conductive hearing loss was directly observed in the index infant; conductive loss is also reported in the expanded cohort.

Sensorineural Hearing Impairment HP:0000407

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She was noted to have congenital moderate-to- severe sensorineural hearing loss in the newborn period and was admitted to intensive care at 6 weeks of age due to poor feeding, lethargy and respiratory distress."

Congenital sensorineural hearing loss was reported in individual 3 of the 2023 series, who carried a de novo early frameshift and had severe multisystem disease.

Low-set Ears HP:0000369

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She was noted to have hypertelorism, low-set ears, and micrognathia. She had a normal echocardiogram."

Low-set ears were recorded in several individuals in the expanded clinical series.

Eye 3

Hypertelorism HP:0000316

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She was noted to have hypertelorism, low-set ears, and micrognathia."

The clinical supplement repeatedly describes hypertelorism in individual cases.

Ptosis HP:0000508

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She had congenital unilateral vocal cord paralysis, short stature (147.5 cm), small HC (< 3rd) ptosis, subaortic ventricular septal defect, myopia, and hypotonia."

Ptosis occurs in several reported individuals, including those with relatively mild craniofacial abnormalities.

Strabismus HP:0000486

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Surgical procedures were performed to correct the cleft palate, as well as strabismus."

Strabismus was surgically corrected in individual 10.

Genitourinary 2

Cryptorchidism HP:0000028

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis."

Cryptorchidism was documented in individual cases, including the p.Met496Ile infant.

Hydronephrosis HP:0000126

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis."

Right hydronephrosis was documented in the p.Met496Ile infant; this is not an established high-frequency feature.

Head and Neck 11

Mandibulofacial Dysostosis HP:0005321

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"All three individuals exhibit varying degrees of mandibulofacial dysostosis, and two additionally have limb anomalies."

Present in all three founding index cases, with marked variation in severity. The broader later cohort includes individuals without this full facial pattern.

Micrognathia HP:0000347

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"severe micrognathia, which required tracheostomy at birth to establish a secure airway"

Mandibular hypoplasia ranges from mild to severe; the index infant required an airway intervention at birth.

Malar Hypoplasia Malar flattening HP:0000272

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"subtle craniofacial dysmorphism including malar hypoplasia, micrognathia, and dysplastic ears."

Malar flattening or zygomatic hypoplasia contributes to the craniofacial phenotype.

Cleft Palate HP:0000175

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"ablepharon, absent zygoma, bilateral anotia, cleft palate, underdeveloped maxilla, micrognathia (severe)"

Cleft palate occurs in both severe craniofacial presentations and the broader 2023 series.

Downslanted Palpebral Fissures HP:0000494

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Initial physical exam of the full-term newborn revealed down-slanting palpebral fissures, severe bilateral lower eyelid clefts, inferiorly displaced orbits, an underdeveloped midface, and extreme micrognathia (Figures 1A–1C)."

Downslanting palpebral fissures were documented in the founding cases.

Eyelid Coloboma HP:0000625

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 1A2, previously described by Wieczorek et al.,22 is a 6-year-old Brazilian female with craniofacial anomalies including short, down-slanting palpebral fissures, upper and lower eyelid clefts, absent medial eyelashes, heminasal aplasia, large ears, and full lips (Figure 2A)."

Upper or lower eyelid clefts occur, with severe bilateral lower eyelid defects in the index infant.

Choanal Atresia HP:0000453

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"bilateral choanal atresia, upper and lower eyelid clefts, microcephaly"

Bilateral choanal atresia occurred in the second founding case and choanal atresia was surgically treated in a later case.

Microcephaly HP:0000252

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"bilateral choanal atresia, upper and lower eyelid clefts, microcephaly"

Microcephaly is documented in some cases but head size is variable.

Metopic Craniosynostosis Metopic synostosis HP:0011330

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"He had bilateral cleft lip and palate, metopic craniosynostosis, and bilateral hydroceles."

Metopic craniosynostosis was documented in the 2023 series, including the p.Asp59Val brothers and individual 14. It cannot be used as an exclusion criterion.

Acalvaria Absent ossification of calvaria HP:0005623

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Head CT with 3D reconstruction of Individual 8 demonstrates (B) almost complete acalvaria at 3 days of age and (C) progressive post-natal ossification evident at 26 months of age."

Near-complete lack of calvarial ossification was documented in the p.Met496Ile infant; serial imaging showed progressive postnatal ossification. The 2023 and 2025 publications describe the same individual.

Cleft Lip Cleft upper lip HP:0000204

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"He had bilateral cleft lip and palate, metopic craniosynostosis, and bilateral hydroceles."

Cleft lip accompanied cleft palate in the p.Asp59Val brothers.

Limbs 8

Femoral Bowing HP:0002980

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses"

Congenital short bowed femora were observed in the severe founding case.

Flared Metaphyses Flared metaphysis HP:0003015

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses"

Metaphyseal flaring accompanied bowed femora in the severe founding case.

Acetabular Dysplasia HP:0008807

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses"

Dysplastic acetabulae were documented in the severe founding case.

Delayed Femoral Epiphyseal Ossification Delayed proximal femoral epiphyseal ossification HP:0008828

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"In addition, individual 1A1 had congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses (Figure 1F)."

Ossification of the capital femoral epiphyses was delayed or absent in the founding infant.

Brachydactyly HP:0001156

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Short, broad fingers of individual IA3."

Short broad fingers and toes were documented in the mildly affected adult founding case.

Radial Aplasia Unilateral radial aplasia HP:0011908

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 12 is a 4.25-year-old male with multiple anomalies including left hemifacial microsomia, unilateral radial aplasia (left), several small ventricular septal defects, and pulmonary artery stenosis."

Unilateral radial aplasia was reported in individual 12 with an inherited truncating variant and normal reported development.

Preaxial Hand Polydactyly HP:0001177

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"X-rays demonstrate duplication of the right thumb with bifid distal phalanx, short medial phalanx of the 5th fingers, radial hemimelia, as well as triphalangeal halluces."

Duplication of the right thumb was documented in individual 10 with a truncating variant.

Clubfoot Talipes equinovarus HP:0001762

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At birth she was noted to have a posterior cleft palate, micrognathia, radial dysplasia, and club feet."

Clubfeet were documented in individual 10 alongside radial and thumb abnormalities.

Musculoskeletal 2

Hypotonia HP:0001252

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Physical exam was notable for microcephaly, congenital nevus on the scalp, hypotonia and micrognathia."

Hypotonia is documented across several cases in the expanded series, particularly those with developmental impairment.

Lower Limb Spasticity HP:0002061

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school."

Lower-limb spasticity was documented with dystonia and motor delay in individual 11, whose reported cognition and brain MRI were normal.

Nervous System 8

Hydrocephalus HP:0000238

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 6 is a 10-year-old female with multiple congenital anomalies: choanal atresia requiring surgical repair, hydrocephalus with C0/C1 stenosis treated with ventriculocisternostomy, and cleft palate."

Hydrocephalus, including aqueductal stenosis in one case, occurred in the expanded cohort. Some patients underwent surgical treatment.

Syringomyelia HP:0003396

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"(A) MRI of individual 6 demonstrates extensive syringomyelia (Left) and ventriculomegaly (Right)."

Extensive syringomyelia was shown on MRI in individual 6.

Global Developmental Delay HP:0001263

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"At age 2 years, his development globally delayed. He was able to make sounds, laugh, roll over, sit with support, enjoy tastes by mouth, and bring items to midline and pass between his hands."

Some patients have severe motor and language delay, whereas other affected individuals have normal development. The p.Met496Ile infant also had neonatal ischemic injury, limiting attribution of all developmental findings to POLR1A.

Seizure HP:0001250

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"His epilepsy has been refractive to multiple medications and he is currently on 5 antiepileptic medications (clobazam, topiramate, phenobarbital, brivaracetam,and rufinimide) having previously tried vigabatrin (ineffective), levetiracetam (behavioral problems), and lacosmide (ineffective)."

Epilepsy ranges from controlled focal seizures to early-onset drug-resistant seizures and infantile spasms. The 2023 cohort included a separate ATP1A1 diagnosis in one individual with severe epilepsy.

Epileptic Encephalopathy HP:0200134

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 9 is an almost 4-year-old male who developed epileptic encephalopathy at age 2.5 years."

Individual 9 developed epileptic encephalopathy with regression after initially normal development; his truncating variant was also present in apparently unaffected relatives.

Vocal Cord Paralysis HP:0001605

Show evidence (2 references)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 4 is an 18-month-old male who presented to genetics for evaluation of bilateral vocal cord paralysis, feeding difficulties, and hypotonia."

Unilateral or bilateral vocal cord paralysis occurred in a mother and child carrying p.Arg393His, classified as uncertain in their clinical report despite an abnormal transcription assay.

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Clinical trio exome sequencing (GeneDx, Gaithersburg, MD) identified a maternally inherited variant in POLR1A c.1178G>A; p.(Arg393His) and a maternally inherited variant in PHEX c.160T>C; p.(Cys54Arg) (NM_000444.6, GRCH 38), both variants of uncertain significance. Clinical SNP microarray was normal."

The clinical report classified the inherited POLR1A and PHEX variants as uncertain.

Sleep Apnea HP:0010535

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen."

Mixed obstructive and central sleep apnea was documented in one p.Asp59Val brother.

Dystonia HP:0001332

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

Dystonia of the legs was reported in individual 11 with p.Val1241Ile. This is a case-specific observation.

Growth 2

Short Stature HP:0004322

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Short stature became more significant with age"

The founding index infant had severe short stature that became more pronounced by age three; stature is not uniformly reduced.

Failure to Thrive HP:0001508

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 14 is a 6-month-old male with craniofacial anomalies, hypotonia, failure to thrive requiring gastrostomy tube placement, unilateral (left) cryptorchidism, right sided inguinal hernia, and developmental delay."

Poor growth and feeding difficulties requiring enteral support are documented in several children.

🧬

Genetic Associations

POLR1A

Gene: POLR1A hgnc:17264 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (4 references)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1."

The founding report identifies heterozygous POLR1A variants.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type"

Engineered HCT116 cells show lower rRNA synthesis for these two alleles.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del."

These alleles increase nascent nucleolar RNA in the engineered cell assay.

+ 1 more reference

💊

Medical Actions

Airway stabilization and tracheostomy

Action: Tracheotomy NCIT:C15341

Platform: Surgery

Severe micrognathia can require tracheostomy at birth. A later child with vocal cord paralysis also required tracheostomy. These are reported interventions for individual anatomy and airway compromise.

Mechanism Target:

BYPASSES Micrognathia — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"severe micrognathia, which required tracheostomy at birth to establish a secure airway"

BYPASSES Vocal Cord Paralysis — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"severe micrognathia, which required tracheostomy at birth to establish a secure airway"

Target Phenotypes: Micrognathia HP:0000347 Vocal cord paralysis HP:0001605

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"severe micrognathia, which required tracheostomy at birth to establish a secure airway"

Gastrostomy feeding

Action: Gastrostomy NCIT:C52006

Platform: Surgery

Gastrostomy was used for aspiration, poor feeding or failure to thrive in several children. Case reports establish its use without comparative outcome estimates.

Mechanism Target:

BYPASSES Failure to Thrive — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"he was diagnosed with frank aspiration, requiring gastrostomy tube placement."

Gastrostomy was used for aspiration, poor feeding or failure to thrive in several children. Case reports establish its use without comparative outcome estimates.

Target Phenotypes: Failure to thrive HP:0001508

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"he was diagnosed with frank aspiration, requiring gastrostomy tube placement."

Gastrostomy was used for aspiration, poor feeding or failure to thrive in several children. Case reports establish its use without comparative outcome estimates.

Craniofacial reconstructive surgery

Action: Reconstructive Surgery NCIT:C25351

Platform: Surgery

Cleft palate and strabismus correction, choanal surgery and craniosynostosis procedures have been used according to the individual malformation. The reports do not provide a standardized operative schedule or comparative benefit.

Mechanism Target:

MODULATES Cleft Palate — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Surgical procedures were performed to correct the cleft palate, as well as strabismus."

MODULATES Choanal Atresia — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Surgical procedures were performed to correct the cleft palate, as well as strabismus."

MODULATES Metopic Craniosynostosis — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Surgical procedures were performed to correct the cleft palate, as well as strabismus."

Target Phenotypes: Cleft palate HP:0000175 Choanal atresia HP:0000453 Metopic synostosis HP:0011330

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Surgical procedures were performed to correct the cleft palate, as well as strabismus."

Antiseizure medication

Action: Anticonvulsant Therapy NCIT:C64172

Platform: Small molecule

Antiseizure medicines are used for clinical epilepsy, with variable response. Some cases require multiple agents, whereas the child with p.Val1631Met had epilepsy controlled on lamotrigine; that allele showed no transcription change in the reported assay.

Mechanism Target:

MODULATES Seizure — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She has generalized epilepsy well controlled on lamotrigine. She required a gastrostomy tube for poor feeding."

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She has generalized epilepsy well controlled on lamotrigine. She required a gastrostomy tube for poor feeding."

Supplemental oxygen for sleep apnea

Action: Oxygen Therapy NCIT:C94624

Platform: Other

One child with mixed obstructive and central apnea received supplemental oxygen after polysomnography. This is a case-specific intervention rather than a general sleep-apnea regimen.

Mechanism Target:

BYPASSES Sleep Apnea — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen. At 4 months of age, his weight gain plateaued, and he was diagnosed with frank aspiration, requiring gastrostomy tube placement."

One child with mixed obstructive and central apnea received supplemental oxygen after polysomnography. This is a case-specific intervention rather than a general sleep-apnea regimen.

Target Phenotypes: Sleep apnea HP:0010535

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

One child with mixed obstructive and central apnea received supplemental oxygen after polysomnography. This is a case-specific intervention rather than a general sleep-apnea regimen.

Surgical treatment of hydrocephalus

Action: Ventriculostomy NCIT:C99771

Platform: Surgery

Hydrocephalus was treated with ventriculocisternostomy in one child and shunting in another. Care depends on the structural cause and clinical assessment.

Mechanism Target:

MODULATES Hydrocephalus — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

Hydrocephalus was treated with ventriculocisternostomy in one child and shunting in another. Care depends on the structural cause and clinical assessment.

Target Phenotypes: Hydrocephalus HP:0000238

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

Hydrocephalus was treated with ventriculocisternostomy in one child and shunting in another. Care depends on the structural cause and clinical assessment.

Orthopedic surgery

Action: Orthopedic Surgical Procedure NCIT:C16186

Platform: Surgery

Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.

Mechanism Target:

MODULATES Lower Limb Spasticity — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.

MODULATES Dystonia — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.

Target Phenotypes: Lower limb spasticity HP:0002061 Dystonia HP:0001332

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.

Individualized cardiac surgery

Action: Cardiovascular Surgical Procedure NCIT:C49803

Platform: Surgery

Cardiac repair was reported in individual 18 with complex defects, but the contribution of p.Pro1638Leu to that phenotype is uncertain after negative functional and mouse findings. Surgical use in that case must not be interpreted as evidence of a POLR1A-specific treatment effect.

Mechanism Target:

MODULATES Atrial Septal Defect — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Septal defects and mitral valve also required surgical repair. She had bilateral hip replacement at age 14 due to severe pain related to osteoarthritis and acetabular protrusion."

MODULATES Ventricular Septal Defect — Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Septal defects and mitral valve also required surgical repair. She had bilateral hip replacement at age 14 due to severe pain related to osteoarthritis and acetabular protrusion."

Target Phenotypes: Atrial septal defect HP:0001631 Ventricular septal defect HP:0001629

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Septal defects and mitral valve also required surgical repair. She had bilateral hip replacement at age 14 due to severe pain related to osteoarthritis and acetabular protrusion."

Mandibular distraction in a reported case

Action: Reconstructive Surgery NCIT:C25351

Platform: Surgery

Mandibular distraction at age seven was reported in individual 18 carrying p.Pro1638Leu. That allele had negative functional and mouse findings, so this is an intervention in a reported, etiologically uncertain case, not evidence of a POLR1A-specific treatment effect.

Target Phenotypes: Micrognathia HP:0000347

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Micrognathia was treated with mandibular distraction at age 7"

🔬

Diagnosis

Molecular genetic testing

Exome or genome sequencing can identify heterozygous POLR1A variants in patients with craniofacial malformations, limb defects or a broader neurodevelopmental presentation. Variant classification, parental testing and clinical concordance matter; a rare variant alone is not diagnostic, especially for alleles with uncertain or negative functional results.

Whole Exome Sequencing NCIT:C101295

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Clinical trio exome sequencing (GeneDx, Gaithersburg, MD) identified a maternally inherited variant in POLR1A c.1178G>A; p.(Arg393His)"

Trio sequencing identified an inherited variant classified as uncertain; clinical interpretation is necessary.

Brain MRI for neurological or structural indications

MRI was used to assess neurological and structural findings in individual cases, including neonatal ischemia and syringomyelia. Normal studies were also reported. These observations do not establish universal screening intervals.

Magnetic Resonance Imaging NCIT:C16809

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Brain MRI at six days of life demonstrated right parietal ischemia"

Echocardiographic assessment

Echocardiography characterized cardiac anatomy in selected patients and was normal in others. The observations support phenotype-directed evaluation, not a quantified screening yield.

Echocardiography Test NCIT:C16525

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Echocardiogram demonstrated anomalous origin of the right coronary"

Echocardiography characterized cardiac anatomy in selected patients and was normal in others. The observations support phenotype-directed evaluation, not a quantified screening yield.

Polysomnography for suspected sleep-disordered breathing

Polysomnography identified mixed obstructive and central apnea in one child. Testing is guided by symptoms and anatomy rather than a syndrome-specific schedule.

Polysomnography NCIT:C114185

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen."

Polysomnography identified mixed obstructive and central apnea in one child. Testing is guided by symptoms and anatomy rather than a syndrome-specific schedule.

📈

Progression

Prenatal and neonatal structural disease

Severe craniofacial malformations may be detected prenatally and cause airway compromise at birth. Other children have milder facial findings with normal development. Severe infantile cardiorespiratory disease and early deaths occur in individual cases, without a reliable survival estimate.

Show evidence (1 reference)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"severe micrognathia, which required tracheostomy at birth to establish a secure airway"

The severe index case required neonatal airway protection.

Variable childhood neurodevelopment

Development ranges from normal to severe impairment with epilepsy. One child developed epileptic encephalopathy and regression after initially normal development. This is not evidence of a universal progressive neurodegenerative course.

Show evidence (1 reference)

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Individual 9 is an almost 4-year-old male who developed epileptic encephalopathy at age 2.5 years."

Later-onset epilepsy with regression is a case-specific trajectory.

📊

Prevalence

Published, clinically ascertained POLR1A cases

Cases In Literature Ultra Rare

The founding report described three index individuals. The 2023 expansion analyzed 18 individuals, including 17 additional individuals and one previously reported case. Related individuals, earlier reports outside the founding series, uncertain variants and repeat publication preclude treating their sum as a complete count of confirmed cases or estimating population prevalence.

Show evidence (2 references)

PMID:25913037 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We report three individuals with a cranioskeletal malformation syndrome that we define as acrofacial dysostosis, Cincinnati type."

The founding cohort contained three index individuals.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Clinical or research exome or genome sequencing identiﬁed 13 heterozygous rare or novel (previously unreported in gno- mAD) variants in POLR1A (GenBank: NM_015425.6) in 18 individuals."

The expanded series contains related individuals and uncertain variants; its denominator is an ascertained study cohort.

🧫

Experimental Models

Human POLR1A variant replacement in HCT116 cells CELL_LINE

Endogenous POLR1A was degraded and variant constructs were tested for nascent nucleolar RNA and localization. This is an engineered cancer-cell assay rather than a patient-derived heterozygous neural crest model.

Cell source

Engineered HCT116 cells with auxin-degradable endogenous POLR1A and transient HaloTag-POLR1A constructs

Publication

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211

Pathograph links

Reduced Pol I rRNA Transcription measures fidelity: moderate p.Arg393His and p.Glu593Gln reduce nucleolar RNA synthesis.

Limitations: Construct replacement and normalization to HaloTag intensity do not reproduce endogenous heterozygous dosage; no universal disease-wide activity deficit follows.

Readouts

Precursor-rRNA or nascent nucleolar RNA signal

Direction: DECREASED

Interpretation: p.Arg393His and p.Glu593Gln reduce nucleolar RNA synthesis.

Show evidence (1 reference)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type"

Engineered HCT116 cells show lower rRNA synthesis for these two alleles.

Show evidence (1 reference)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type"

Engineered HCT116 cells show lower rRNA synthesis for these two alleles.

Increased Pol I rRNA Transcription measures fidelity: moderate p.Asp59Val, p.Glu1330del and p.Cys1562Phe increase the RNA signal; two other alleles increase it mildly.

Limitations: p.Pro1638Leu and p.Val1631Met show no change. Effects do not consistently predict clinical severity or organ involvement.

Readouts

Nascent nucleolar RNA signal

Direction: INCREASED

Interpretation: p.Asp59Val, p.Glu1330del and p.Cys1562Phe increase the RNA signal; two other alleles increase it mildly.

Show evidence (1 reference)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del."

These alleles increase nascent nucleolar RNA in the engineered cell assay.

Show evidence (1 reference)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del."

These alleles increase nascent nucleolar RNA in the engineered cell assay.

Inducible POLR1A p.Glu593Gln in HeLa cells CELL_LINE

Mutant expression at approximately twice the endogenous level produces abnormal condensates containing wild-type polymerase and suppresses nascent RNA and precursor rRNA. Tracking data support a dominant-negative interference model.

Cell source

HeLa S3 cells with tagged endogenous polymerase and inducible mutant expression

Publication

PMID:33055158

Pathograph links

Abnormal Pol I Condensate Formation measures fidelity: moderate Mutant and wild-type polymerase relocalize to abnormal condensates.

Limitations: Stable rDNA association and competition are inferred from tracking and localization; the experiment is not a patient neural crest assay.

Show evidence (1 reference)

PMID:33055158 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Not only the mutant but also the WT Pol I was localized to the condensates (HaloTag-WT RPA194; Fig. 4A), suggesting that mutant Pol I compromised the stable Pol I cluster."

Mutant and wild-type polymerase relocalize in an inducible HeLa overexpression experiment.

Reduced Pol I rRNA Transcription measures fidelity: moderate 47S precursor rRNA decreases markedly after mutant induction.

Limitations: The reported 30% value is cellular transcript abundance relative to controls, not residual activity of purified patient enzyme.

Readouts

Precursor-rRNA or nascent nucleolar RNA signal

Direction: DECREASED

Interpretation: 47S precursor rRNA decreases markedly after mutant induction.

Show evidence (1 reference)

PMID:33055158 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the 47S pre-rRNA transcript was decreased to 30% in cells expressing RPA194-E593Q compared with control cells"

Precursor-rRNA output decreases in the induced cell model.

Show evidence (1 reference)

PMID:33055158 SUPPORT DIRECT PRIMARY RESULT In Vitro

"the 47S pre-rRNA transcript was decreased to 30% in cells expressing RPA194-E593Q compared with control cells"

Precursor-rRNA output decreases in the induced cell model.

Tamoxifen-induced Polr1a deletion in mouse embryonic fibroblasts PRIMARY_CELL_CULTURE

Co-immunoprecipitation examines the ribosomal-protein/Mdm2/p53 interaction mechanism in cultured fibroblasts. Parallel Polr1c and Tcof1 manipulations support a shared pathway but are not additional human POLR1A alleles.

Cell source

Mouse embryonic fibroblasts with inducible CreERT2 deletion

Publication

PMID:35881792

Pathograph links

Increased RPL5 and RPL11 Binding to MDM2 measures fidelity: moderate Rpl5 and Rpl11 binding to Mdm2 increases.

Limitations: Total abundance of the assayed proteins was unchanged. The proposed free-ribosomal-protein imbalance was not directly quantified in patient neural crest.

Readouts

MDM2-associated RPL5 and RPL11 abundance

Direction: INCREASED

Interpretation: Rpl5 and Rpl11 binding to Mdm2 increases.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls"

Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls"

Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.

Reduced MDM2 Binding to p53 measures fidelity: moderate Mdm2-p53 co-immunoprecipitation decreases.

Limitations: This interaction readout does not directly measure the rate of p53 degradation in an embryo.

Readouts

MDM2-associated p53 abundance

Direction: DECREASED

Interpretation: Mdm2-p53 co-immunoprecipitation decreases.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls"

Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls"

Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.

🐁

Animal Models

polr1a mutant zebrafish with genetic tp53 suppression

The homozygous insertional mutant models reduced Polr1a function. tp53 M214K produces nonfunctional DNA-binding-domain protein; the paper abbreviates this as tp53 knockout, but it is not a genomic deletion. Early apoptosis and morphology improve, while later cartilage development and survival remain abnormal. Some double mutants survive to eight rather than five days. This dose and developmental timing differ from heterozygous human disease.

Species

Zebrafish

Genotype

Homozygous polr1a hi3639Tg, with or without homozygous tp53 M214K

Publication

PMID:29750247

Pathograph links

Reduced Pol I rRNA Transcription measures fidelity: moderate Precursor-rRNA spacer abundance falls in the mutant and is not restored by tp53 inhibition.

Limitations: RT-qPCR is a transcription proxy. Mature 18S RNA is unchanged at 24 hours but decreases at 48 hours; residual rRNA remains.

Readouts

Precursor-rRNA or nascent nucleolar RNA signal

Direction: DECREASED

Interpretation: Precursor-rRNA spacer abundance falls in the mutant and is not restored by tp53 inhibition.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

Reduced Ribosome Availability measures fidelity: moderate Monosome and polysome profiles decrease.

Limitations: Polysome profiling used pooled whole embryos at three days, not purified neural crest cells.

Readouts

Monosome and polysome abundance

Direction: DECREASED

Interpretation: Monosome and polysome profiles decrease.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation"

Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.

Reduced Protein Translation measures fidelity: moderate Radiolabeled methionine incorporation measures reduced protein synthesis.

Limitations: The assay used dissociated cells from whole embryos at 24 hours and did not demonstrate neural crest-specific translation or translation rescue in the double mutant.

Readouts

Radiolabeled methionine incorporation

Direction: DECREASED

Interpretation: Radiolabeled methionine incorporation measures reduced protein synthesis.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Consistent with these ideas, we confirmed through35S-Met incorporation that there was indeed a significant 75% reduction in protein synthesis inpolr1a–/–mutant zebrafish compared with controls (Fig."

Radiolabeled methionine incorporation was measured in cells dissociated from 24-hour embryos, not isolated neural crest cells.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

Radiolabeled methionine incorporation was measured in cells dissociated from 24-hour embryos, not isolated neural crest cells.

Early Neuroepithelial and Neural Crest Apoptosis rescues fidelity: moderate tp53 M214K suppresses early neuroepithelial TUNEL labeling.

Limitations: Protection is temporary: apoptosis approaches controls at 24–48 hours but recurs by 60 hours. Cartilage rescue is partial.

Readouts

Early TUNEL-positive cell abundance after tp53 suppression

Direction: DECREASED

Interpretation: tp53 M214K suppresses early neuroepithelial TUNEL labeling.

Show evidence (2 references)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype."

Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.

+ 1 more reference

Show evidence (2 references)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype."

Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.

+ 1 more reference

Reduced Neural Crest Cell Proliferation measures fidelity: moderate Arch neural crest proliferation remains reduced at 36 hours in both mutant backgrounds.

Limitations: The 24-hour comparison is not significant. Global proliferation improves with tp53 suppression, so the residual effect is not universal to all cells.

Readouts

Proliferating arch neural crest cell fraction

Direction: DECREASED

Interpretation: Arch neural crest proliferation remains reduced at 36 hours in both mutant backgrounds.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.

Show evidence (1 reference)

PMID:29750247 SUPPORT DIRECT PRIMARY RESULT Model Organism

The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.

Early neural crest-restricted Polr1a deletion in mouse

Early neural crest-restricted deletion produces severe craniofacial malformations and cell loss. Wnt1-Cre affects earlier progenitors than Sox10-Cre. C1559F with conditional removal of the other allele is less severe and shows later apoptosis than the null; it is not the same genotype as a human heterozygote.

Species

Mouse

Genotype

Polr1a conditional loss with Wnt1-Cre; related Sox10-Cre null and C1559F models

Publication

PMID:35881792

Pathograph links

Reduced Pol I rRNA Transcription measures fidelity: moderate Sorted neural crest cells have reduced precursor-rRNA signal.

Limitations: Total protein measured by silver staining is not a direct translation-rate assay in these mutants.

Readouts

Precursor-rRNA or nascent nucleolar RNA signal

Direction: DECREASED

Interpretation: Sorted neural crest cells have reduced precursor-rRNA signal.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT Model Organism

"qPCR for the 5′ETS region of rRNA is significantly reduced in the sorted NCCs of Polr1aNKO/NKO and Tcof1NKO/NKO embryos"

The precursor-rRNA measurement is directly in sorted mouse neural crest cells.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT Model Organism

"qPCR for the 5′ETS region of rRNA is significantly reduced in the sorted NCCs of Polr1aNKO/NKO and Tcof1NKO/NKO embryos"

The precursor-rRNA measurement is directly in sorted mouse neural crest cells.

Early Neuroepithelial and Neural Crest Apoptosis rescues fidelity: moderate Neural crest loss contributes to craniofacial hypoplasia; p53 inhibition improves early arch development.

Limitations: Pifithrin-alpha was tested in embryo culture; three of four treated mutants had larger arches, but survival beyond E12.5 was not rescued. This is not patient treatment evidence.

Show evidence (1 reference)

PMID:35881792 SUPPORT DIRECT PRIMARY RESULT In Vitro

"showed a considerable increase in the volume of the pharyngeal arches in concert with increased YFP+ cells in the arches and frontonasal prominences (n = 3/4)"

Pharmacologic rescue was partial and measured in embryonic culture.

Anterior heart-field conditional Polr1a deletion

Anterior heart-field deletion causes an underdeveloped right ventricle, shortened outflow tract and a large ventricular septal defect. A focal CC3 increase was observed but the quantified apoptosis comparison was not significant.

Species

Mouse

Genotype

Polr1a null/flox; Mef2c-AHF-Cre

Publication

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211

Forebrain conditional Polr1a loss and C1559F

Both genotypes produce a hypoplastic telencephalon, with greater anatomical severity in the null. At the sampled stage, CC3 elevation is significant in C1559F but not the null; bulk RNA findings also differ by allele.

Species

Mouse

Genotype

Polr1a null/flox or C1559F/flox; Foxg1-Cre

Publication

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211

Pathograph links

Heterozygous POLR1A Variants perturbs fidelity: low Orthologous Polr1a manipulation tests the developmental requirement in forebrain progenitors.

Limitations: The experimental genotypes are conditional null or variant-only in the targeted lineage, rather than a patient heterozygote. Brain morphology is measured; human cognition, epilepsy and a uniform apoptosis sequence are not.

Show evidence (1 reference)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the data demonstrate hypoplastic telen- cephalons in both mutants compared to controls"

Both conditional genotypes alter forebrain development.

Polr1a germline variant knock-in mice

Heterozygotes are healthy and fertile. Homozygous C1559F is embryonic lethal before E7, whereas P1635L homozygotes and P1635L/null animals have normal measured phenotypes. An additional humanized adjacent-residue line also lacks the proposed phenotype.

Species

Mouse

Genotype

C1559F and P1635L, orthologous to human C1562F and P1638L; additional A1632V/P1635L line

Publication

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211

Pathograph links

Heterozygous POLR1A Variants perturbs fidelity: low Knock-in models compare the effects of specific orthologous variants.

Limitations: Negative P1635L transcription and mouse results weaken attribution of individual 18’s findings to p.Pro1638Leu. Normal heterozygous mice and severe homozygous phenotypes prevent treating either line as a complete human phenocopy.

Show evidence (2 references)

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Polr1aP1635L/null adult animals in the expected Mendelian ratios and with normal phenotypes"

P1635L is tolerated even in trans with a null allele.

+ 1 more reference

Late migratory and post-migratory temporal Polr1a deletion

Ubiquitous temporal recombination is followed by analysis at E12.5. This is not a neural crest-restricted deletion. Single-cell data show mixed relative cell-type shifts; microCT and SOX9 labeling show preferential disruption of facial skeletal structures.

Species

Mouse

Genotype

Polr1a flox/flox; R26-CreERT2, tamoxifen at E9.0–9.5

Publication

PMID:41803115

Pathograph links

Impaired Later Craniofacial Skeletogenesis measures fidelity: moderate SOX9 signal and cartilage development decrease after temporal deletion.

Limitations: Neither apoptosis nor proliferation was directly assayed in these developmental mutants, so fate conversion cannot be distinguished from survival or expansion. No heterozygous human variant was tested.

Readouts

Mandibular SOX9 signal

Direction: DECREASED

Interpretation: SOX9 signal and cartilage development decrease after temporal deletion.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development."

Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development."

Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.

Reduced Craniofacial Skeletal Condensations measures fidelity: moderate Facial condensations decrease and Meckel cartilage becomes discontinuous.

Limitations: Relative preservation of trigeminal ganglion volume does not establish normal neural function or absolute neuroglial expansion.

Readouts

Facial mesenchymal condensation volume

Direction: DECREASED

Interpretation: Facial condensations decrease and Meckel cartilage becomes discontinuous.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected"

The structural comparison demonstrates different tissue sensitivity.

Show evidence (1 reference)

PMID:41803115 SUPPORT DIRECT PRIMARY RESULT Model Organism

"whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected"

The structural comparison demonstrates different tissue sensitivity.

{ }

Source YAML

click to show

name: Acrofacial Dysostosis Cincinnati Type
creation_date: '2026-09-02T00:00:00Z'
category: Mendelian
disease_term:
  preferred_term: acrofacial dysostosis Cincinnati type
  term:
    id: MONDO:0014651
    label: acrofacial dysostosis Cincinnati type
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0014651
      label: acrofacial dysostosis Cincinnati type
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
synonyms:
- AFDCIN
- acrofacial dysostosis, Cincinnati type
- POLR1A-related acrofacial dysostosis
- Cincinnati type acrofacial dysostosis
parents:
- Acrofacial dysostosis
- Mandibulofacial dysostosis
- Ribosomopathy
description: 'Acrofacial dysostosis Cincinnati type is a POLR1A-related developmental disorder initially recognized by mandibulofacial dysostosis with variable limb abnormalities. Heterozygous variants can also be associated with developmental impairment, epilepsy and congenital cardiac anomalies, while some individuals have mild craniofacial findings and normal development. Both de novo and inherited variants occur. POLR1A encodes the largest catalytic subunit of RNA polymerase I. Experimental effects vary by allele: some variants decrease ribosomal RNA transcription, some increase it, and others have no detectable effect in the tested assays. Reduced transcription and ribosomal stress cause early neural crest or neuroepithelial cell loss in animal models; later cartilage development also requires Polr1a. These model mechanisms do not establish a uniform biochemical defect or a complete explanation for every human phenotype.'
notes: The clinical spectrum is based on small, clinically ascertained reports rather than population sampling. The 2023 study included 18 individuals with 13 heterozygous variants, including relatives, an already reported individual, and variants classified as uncertain, likely pathogenic or pathogenic. Its abstract describes 17 additional individuals and 12 additional variants. Individual findings and cohort counts below are not population frequency estimates. The 2025 p.Met496Ile case overlaps individual 8 in the 2023 series and is not an independent additional case; the reports differ on age at death. True metopic craniosynostosis, hearing impairment and occasional larger head circumference are documented, so their absence cannot define or exclude this disorder. A second de novo ATP1A1 variant confounds individual 13, while p.Pro1638Leu in individual 18 remains questionable after negative functional studies. The 2023 full article and clinical supplement are cited by their generated public URL records; the article corresponds to PMID:37075751. Autosomal recessive POLR1A-associated neurodegenerative disease is a separate reported phenotype and is not generalized to this entry. Canonical
  PMID:37075751 was refetched through the tracked PMC HTML adapter on September 21, 2026, but remained abstract-only; the institutional full-article PDF is therefore retained for verified body quotations. Its bibliographic title is POLR1A variants underlie phenotypic heterogeneity in craniofacial, neural, and cardiac anomalies. The publisher PDF contains the associated supplemental case reports. Generated PDF URL records use the URL as title and the fetch command provides no title override; this metadata limitation is tracked in https://github.com/monarch-initiative/dismech/issues/12417. The experimental cranial-precursor mechanism informs skeletal hypoplasia, but does not establish the individual developmental route to every human ear, eyelid, lip or airway malformation.
prevalence:
- population: Published, clinically ascertained POLR1A cases
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: The founding report described three index individuals. The 2023 expansion analyzed 18 individuals, including 17 additional individuals and one previously reported case. Related individuals, earlier reports outside the founding series, uncertain variants and repeat publication preclude treating their sum as a complete count of confirmed cases or estimating population prevalence.
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We report three individuals with a cranioskeletal malformation syndrome that we define as acrofacial dysostosis, Cincinnati type.
    explanation: The founding cohort contained three index individuals.
  - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 'Clinical or research exome or genome sequencing identiﬁed 13 heterozygous rare or novel (previously unreported in gno- mAD) variants in POLR1A (GenBank: NM_015425.6) in 18 individuals.'
    explanation: The expanded series contains related individuals and uncertain variants; its denominator is an ascertained study cohort.
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: Heterozygous pathogenic POLR1A variants can arise de novo or be transmitted. Inherited variants have been observed in mildly affected or apparently unaffected parents; variant-specific uncertainty and subtle parental findings prevent a penetrance estimate.
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1.
    explanation: The founding human cases establish heterozygous variants.
  - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: ﬁve individuals (1, 2, 9, 10, and 12) inherited their variant from a reportedly unaffected parent.
    explanation: The study documents transmission from reportedly unaffected parents, with possible subtle findings and uncertain penetrance.
mechanistic_hypotheses:
- hypothesis_group_id: pol1_nucleolar_stress_ncc_apoptosis
  hypothesis_label: Reduced Pol I transcription and early neural crest depletion
  status: CANONICAL
  description: Experimental Polr1a loss reduces precursor rRNA and ribosome production. Ribosomal protein-Mdm2 interactions, p53 pathway activity and apoptosis support a stress-mediated depletion mechanism in early developmental models. The molecular interaction assays were performed in mouse embryonic fibroblasts, and the developmental phenotypes in fish and mouse embryos. Human allele effects are heterogeneous; this model describes the reduced-function branch rather than every POLR1A variant.
- hypothesis_group_id: pol1_p53_independent_arm
  hypothesis_label: Residual developmental defects after p53 inhibition
  status: EMERGING
  description: Genetic tp53 inhibition incompletely rescues polr1a-mutant zebrafish cartilage and does not restore rRNA transcription or neural crest proliferation. Additional growth and developmental requirements remain, although later apoptosis also recurs. The residual defects do not establish complete apoptosis independence.
- hypothesis_group_id: pol1_late_skeletogenesis
  hypothesis_label: Later Polr1a requirement for craniofacial skeletal development
  status: EMERGING
  description: Ubiquitous temporal Polr1a deletion after early neural crest migration reduces mandibular SOX9 and skeletal condensations. This establishes a later experimental requirement without distinguishing altered differentiation, proliferation or survival; p53 was not perturbed in that experiment.
pathophysiology:
- name: Heterozygous POLR1A Variants
  biological_scale: MOLECULAR
  description: Germline heterozygous variants are associated with the human disorder. Missense, truncating and in-frame alleles have diverse experimental effects; neither uniform haploinsufficiency nor universal loss of function is established.
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1.
    explanation: Human cases establish the heterozygous POLR1A association.
  genes:
  - preferred_term: POLR1A
    term:
      id: hgnc:17264
      label: POLR1A
  genetic_context:
    description: De novo or inherited heterozygous POLR1A variants; functional consequences are allele-specific.
    variant_origin: GERMLINE
    zygosity: HETEROZYGOUS
  downstream:
  - target: Abnormal Pol I Condensate Formation
    description: p.Glu593Gln alters polymerase localization in an overexpression model; physiological heterozygous dosage in patient tissue was not tested.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33055158
      reference_title: Transcriptional suppression of ribosomal DNA with phase separation.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Not only the mutant but also the WT Pol I was localized to the condensates (HaloTag-WT RPA194; Fig. 4A), suggesting that mutant Pol I compromised the stable Pol I cluster.
      explanation: Mutant and wild-type polymerase relocalize in an inducible HeLa overexpression experiment.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
  - target: Reduced Pol I rRNA Transcription
    description: Some alleles, including p.Arg393His and p.Glu593Gln, reduce rRNA synthesis in the tested cell context.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type
      explanation: Engineered HCT116 cells show lower rRNA synthesis for these two alleles.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
  - target: Increased Pol I rRNA Transcription
    description: Other alleles increase nascent nucleolar RNA in the engineered cell assay.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del.
      explanation: These alleles increase nascent nucleolar RNA in the engineered cell assay.
  - target: Impaired Later Craniofacial Skeletogenesis
    description: Temporal mouse Polr1a loss establishes a later developmental requirement; the bridge from heterozygous human variants remains indirect.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:41803115
      reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development.
      explanation: Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.
    hypothesis_groups:
    - pol1_late_skeletogenesis
  - target: Cleft Palate
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: ablepharon, absent zygoma, bilateral anotia, cleft palate, underdeveloped maxilla, micrognathia (severe)
      explanation: Cleft palate occurs in both severe craniofacial presentations and the broader 2023 series.
  - target: Hypertelorism
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: She was noted to have hypertelorism, low-set ears, and micrognathia.
      explanation: The clinical supplement repeatedly describes hypertelorism in individual cases.
  - target: Downslanted Palpebral Fissures
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Initial physical exam of the full-term newborn revealed down-slanting palpebral fissures, severe bilateral lower eyelid clefts, inferiorly displaced orbits, an underdeveloped midface, and extreme micrognathia (Figures 1A–1C).
      explanation: Downslanting palpebral fissures were documented in the founding cases.
  - target: Eyelid Coloboma
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 1A2, previously described by Wieczorek et al.,22 is a 6-year-old Brazilian female with craniofacial anomalies including short, down-slanting palpebral fissures, upper and lower eyelid clefts, absent medial eyelashes, heminasal aplasia, large ears, and full lips (Figure 2A).
      explanation: Upper or lower eyelid clefts occur, with severe bilateral lower eyelid defects in the index infant.
  - target: Anotia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Bilateral anotia and severe conductive hearing loss were present. At birth, head circumference was 33 cm (−1.7 SDs), length was 43 cm (−4 SDs), and weight was 2.4 kg (−2.5 SDs).
      explanation: Bilateral absence of external ears was documented in the severely affected index infant.
  - target: Microtia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: down-slanting palpebral fissures, malar flattening, unilateral microtia, micrognathia (mild)
      explanation: Unilateral microtia was recorded in the adult founding case.
  - target: Conductive Hearing Impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Bilateral anotia and severe conductive hearing loss were present. At birth, head circumference was 33 cm (−1.7 SDs), length was 43 cm (−4 SDs), and weight was 2.4 kg (−2.5 SDs).
      explanation: Severe conductive hearing loss was directly observed in the index infant; conductive loss is also reported in the expanded cohort.
  - target: Sensorineural Hearing Impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: She was noted to have congenital moderate-to- severe sensorineural hearing loss in the newborn period and was admitted to intensive care at 6 weeks of age due to poor feeding, lethargy and respiratory distress.
      explanation: Congenital sensorineural hearing loss was reported in individual 3 of the 2023 series, who carried a de novo early frameshift and had severe multisystem disease.
  - target: Choanal Atresia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: bilateral choanal atresia, upper and lower eyelid clefts, microcephaly
      explanation: Bilateral choanal atresia occurred in the second founding case and choanal atresia was surgically treated in a later case.
  - target: Microcephaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: bilateral choanal atresia, upper and lower eyelid clefts, microcephaly
      explanation: Microcephaly is documented in some cases but head size is variable.
  - target: Metopic Craniosynostosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: He had bilateral cleft lip and palate, metopic craniosynostosis, and bilateral hydroceles.
      explanation: Metopic craniosynostosis was documented in the 2023 series, including the p.Asp59Val brothers and individual 14. It cannot be used as an exclusion criterion.
  - target: Acalvaria
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Head CT with 3D reconstruction of Individual 8 demonstrates (B) almost complete acalvaria at 3 days of age and (C) progressive post-natal ossification evident at 26 months of age.
      explanation: Near-complete lack of calvarial ossification was documented in the p.Met496Ile infant; serial imaging showed progressive postnatal ossification. The 2023 and 2025 publications describe the same individual.
  - target: Short Stature
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Short stature became more significant with age
      explanation: The founding index infant had severe short stature that became more pronounced by age three; stature is not uniformly reduced.
  - target: Femoral Bowing
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses
      explanation: Congenital short bowed femora were observed in the severe founding case.
  - target: Flared Metaphyses
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses
      explanation: Metaphyseal flaring accompanied bowed femora in the severe founding case.
  - target: Acetabular Dysplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses
      explanation: Dysplastic acetabulae were documented in the severe founding case.
  - target: Delayed Femoral Epiphyseal Ossification
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: In addition, individual 1A1 had congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses (Figure 1F).
      explanation: Ossification of the capital femoral epiphyses was delayed or absent in the founding infant.
  - target: Brachydactyly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Short, broad fingers of individual IA3.
      explanation: Short broad fingers and toes were documented in the mildly affected adult founding case.
  - target: Radial Aplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 12 is a 4.25-year-old male with multiple anomalies including left hemifacial microsomia, unilateral radial aplasia (left), several small ventricular septal defects, and pulmonary artery stenosis.
      explanation: Unilateral radial aplasia was reported in individual 12 with an inherited truncating variant and normal reported development.
  - target: Preaxial Hand Polydactyly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: X-rays demonstrate duplication of the right thumb with bifid distal phalanx, short medial phalanx of the 5th fingers, radial hemimelia, as well as triphalangeal halluces.
      explanation: Duplication of the right thumb was documented in individual 10 with a truncating variant.
  - target: Clubfoot
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: At birth she was noted to have a posterior cleft palate, micrognathia, radial dysplasia, and club feet.
      explanation: Clubfeet were documented in individual 10 alongside radial and thumb abnormalities.
  - target: Atrial Septal Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis.
      explanation: An atrial septal defect was reported in the p.Met496Ile infant.
  - target: Ventricular Septal Defect
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: She had congenital unilateral vocal cord paralysis, short stature (147.5 cm), small HC (< 3rd) ptosis, subaortic ventricular septal defect, myopia, and hypotonia.
      explanation: Ventricular septal defects are documented in several individuals in the expanded series.
  - target: Patent Ductus Arteriosus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Other | short stature | patent ductus arteriosus |
      explanation: Patent ductus arteriosus was recorded in the second founding case and in later reports.
  - target: Hypertrophic Cardiomyopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: She was found to have hypertrophic cardiomyopathy and elevated lactate.
      explanation: Hypertrophic cardiomyopathy was documented in the severely affected infant with a de novo early frameshift; this is an individual observation.
  - target: Hydrocephalus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: 'Individual 6 is a 10-year-old female with multiple congenital anomalies: choanal atresia requiring surgical repair, hydrocephalus with C0/C1 stenosis treated with ventriculocisternostomy, and cleft palate.'
      explanation: Hydrocephalus, including aqueductal stenosis in one case, occurred in the expanded cohort. Some patients underwent surgical treatment.
  - target: Syringomyelia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: (A) MRI of individual 6 demonstrates extensive syringomyelia (Left) and ventriculomegaly (Right).
      explanation: Extensive syringomyelia was shown on MRI in individual 6.
  - target: Hypotonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Physical exam was notable for microcephaly, congenital nevus on the scalp, hypotonia and micrognathia.
      explanation: Hypotonia is documented across several cases in the expanded series, particularly those with developmental impairment.
  - target: Global Developmental Delay
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: At age 2 years, his development globally delayed. He was able to make sounds, laugh, roll over, sit with support, enjoy tastes by mouth, and bring items to midline and pass between his hands.
      explanation: Some patients have severe motor and language delay, whereas other affected individuals have normal development. The p.Met496Ile infant also had neonatal ischemic injury, limiting attribution of all developmental findings to POLR1A.
  - target: Seizure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: His epilepsy has been refractive to multiple medications and he is currently on 5 antiepileptic medications (clobazam, topiramate, phenobarbital, brivaracetam,and rufinimide) having previously tried vigabatrin (ineffective), levetiracetam (behavioral problems), and lacosmide (ineffective).
      explanation: Epilepsy ranges from controlled focal seizures to early-onset drug-resistant seizures and infantile spasms. The 2023 cohort included a separate ATP1A1 diagnosis in one individual with severe epilepsy.
  - target: Epileptic Encephalopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 9 is an almost 4-year-old male who developed epileptic encephalopathy at age 2.5 years.
      explanation: Individual 9 developed epileptic encephalopathy with regression after initially normal development; his truncating variant was also present in apparently unaffected relatives.
  - target: Vocal Cord Paralysis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 4 is an 18-month-old male who presented to genetics for evaluation of bilateral vocal cord paralysis, feeding difficulties, and hypotonia.
      explanation: Unilateral or bilateral vocal cord paralysis occurred in a mother and child carrying p.Arg393His, classified as uncertain in their clinical report despite an abnormal transcription assay.
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Clinical trio exome sequencing (GeneDx, Gaithersburg, MD) identified a maternally inherited variant in POLR1A c.1178G>A; p.(Arg393His) and a maternally inherited variant in PHEX c.160T>C; p.(Cys54Arg) (NM_000444.6, GRCH 38), both variants of uncertain significance. Clinical SNP microarray was normal.
      explanation: The clinical report classified the inherited POLR1A and PHEX variants as uncertain.
  - target: Failure to Thrive
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 14 is a 6-month-old male with craniofacial anomalies, hypotonia, failure to thrive requiring gastrostomy tube placement, unilateral (left) cryptorchidism, right sided inguinal hernia, and developmental delay.
      explanation: Poor growth and feeding difficulties requiring enteral support are documented in several children.
  - target: Cryptorchidism
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis.
      explanation: Cryptorchidism was documented in individual cases, including the p.Met496Ile infant.
  - target: Hydronephrosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis.
      explanation: Right hydronephrosis was documented in the p.Met496Ile infant; this is not an established high-frequency feature.
  - target: Sleep Apnea
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen.
      explanation: Mixed obstructive and central sleep apnea was documented in one p.Asp59Val brother.
  - target: Ptosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: She had congenital unilateral vocal cord paralysis, short stature (147.5 cm), small HC (< 3rd) ptosis, subaortic ventricular septal defect, myopia, and hypotonia.
      explanation: Ptosis occurs in several reported individuals, including those with relatively mild craniofacial abnormalities.
  - target: Cleft Lip
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: He had bilateral cleft lip and palate, metopic craniosynostosis, and bilateral hydroceles.
      explanation: Cleft lip accompanied cleft palate in the p.Asp59Val brothers.
  - target: Lower Limb Spasticity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
      explanation: Lower-limb spasticity was documented with dystonia and motor delay in individual 11, whose reported cognition and brain MRI were normal.
  - target: Dystonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
      explanation: Dystonia of the legs was reported in individual 11 with p.Val1241Ile. This is a case-specific observation.
  - target: Strabismus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Surgical procedures were performed to correct the cleft palate, as well as strabismus.
      explanation: Strabismus was surgically corrected in individual 10.
  - target: Low-set Ears
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The reported POLR1A-associated clinical spectrum includes this finding. Tissue intermediates and variant-specific attribution remain unresolved; individual-case and variant-classification limits are stated with the phenotype.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: She was noted to have hypertelorism, low-set ears, and micrognathia. She had a normal echocardiogram.
      explanation: Low-set ears were recorded in several individuals in the expanded clinical series.
- name: Abnormal Pol I Condensate Formation
  biological_scale: MOLECULAR
  description: Inducible p.Glu593Gln POLR1A in HeLa cells produces abnormal nucleolar condensates containing mutant and wild-type polymerase. Single-molecule tracking supports stable mutant association and impaired productive wild-type binding as a dominant-negative model. Expression was approximately twice the endogenous level; this is not a measurement in patient neural crest cells.
  evidence:
  - reference: PMID:33055158
    reference_title: Transcriptional suppression of ribosomal DNA with phase separation.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Not only the mutant but also the WT Pol I was localized to the condensates (HaloTag-WT RPA194; Fig. 4A), suggesting that mutant Pol I compromised the stable Pol I cluster.
    explanation: Mutant and wild-type polymerase relocalize in an inducible HeLa overexpression experiment.
  cellular_components:
  - preferred_term: nucleolus
    term:
      id: GO:0005730
      label: nucleolus
  downstream:
  - target: Reduced Pol I rRNA Transcription
    description: Dominant-negative interference with productive transcription is supported in the engineered assay; chromatin-binding competition is an inferred molecular explanation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33055158
      reference_title: Transcriptional suppression of ribosomal DNA with phase separation.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: the 47S pre-rRNA transcript was decreased to 30% in cells expressing RPA194-E593Q compared with control cells
      explanation: The induced mutant markedly reduces precursor rRNA in the cell assay.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
- name: Reduced Pol I rRNA Transcription
  biological_scale: MOLECULAR
  description: Reduced precursor-rRNA output occurs in polr1a-mutant zebrafish and Polr1a-deleted mouse neural crest, and in cells expressing selected human variants. Spacer-region qPCR is a transcription proxy. Mature rRNA abundance can initially remain unchanged; this branch does not apply to every allele.
  evidence:
  - &id001
    reference: PMID:29750247
    reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
    explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
  - &id005
    reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type
    explanation: Engineered HCT116 cells show lower rRNA synthesis for these two alleles.
  conforms_to: pol1_nucleolar_stress_neural_crest_apoptosis#Reduced Pol I rRNA Transcription
  biological_processes:
  - preferred_term: transcription by RNA polymerase I
    term:
      id: GO:0006360
      label: transcription by RNA polymerase I
    modifier: DECREASED
  cellular_components:
  - preferred_term: nucleolus
    term:
      id: GO:0005730
      label: nucleolus
  downstream:
  - target: Reduced Ribosome Availability
    description: Lower precursor-rRNA output is linked to reduced monosome and polysome abundance in the fish model.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
      explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
  - target: Increased RPL5 and RPL11 Binding to MDM2
    description: A proposed imbalance between reduced rRNA and unchanged ribosomal proteins alters Mdm2 interactions in knockout fibroblasts; free-protein stoichiometry was not directly established in human neural crest.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
      explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
  - target: Reduced Neural Crest Cell Proliferation
    description: The fish model retains a proliferation deficit when early tp53-mediated apoptosis is suppressed; the intervening mechanism is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: The percentage of proliferating neural crest cells in 36 hpf control embryos was 13.24% (n= 5), although inpolr1a–/–(n= 6) andpolr1a–/–;tp53–/–(n= 6) embryos it was 6.00% and 6.38%, respectively.
      explanation: The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.
    hypothesis_groups:
    - pol1_p53_independent_arm
- name: Increased Pol I rRNA Transcription
  biological_scale: MOLECULAR
  description: Nascent nucleolar RNA increases with p.Asp59Val, p.Glu1330del and p.Cys1562Phe in engineered HCT116 cells after endogenous POLR1A depletion. p.Met496Ile and p.Val1241Ile show milder increases. These assays establish neither increased ribosome output in patients nor a causal link to a particular clinical feature.
  evidence:
  - &id006
    reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del.
    explanation: These alleles increase nascent nucleolar RNA in the engineered cell assay.
  biological_processes:
  - preferred_term: transcription by RNA polymerase I
    term:
      id: GO:0006360
      label: transcription by RNA polymerase I
    modifier: INCREASED
- name: Reduced Ribosome Availability
  biological_scale: MOLECULAR
  description: Monosome and polysome profiles are reduced in mutant zebrafish. This is a separate measured consequence from precursor-rRNA abundance and protein translation.
  evidence: &id002
  - *id001
  downstream:
  - target: Reduced Protein Translation
    description: Reduced ribosome profiles accompany lower protein synthesis in the fish model, consistent with limited translational capacity.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
      explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
- name: Reduced Protein Translation
  biological_scale: MOLECULAR
  description: The zebrafish mutant has impaired protein translation. Mouse neural crest knockout studies also show reduced total protein by silver staining, which does not by itself measure translation rate.
  evidence: *id002
  biological_processes:
  - preferred_term: translation
    term:
      id: GO:0006412
      label: translation
    modifier: DECREASED
- name: Increased RPL5 and RPL11 Binding to MDM2
  biological_scale: MOLECULAR
  description: Co-immunoprecipitation in tamoxifen-deleted mouse embryonic fibroblasts shows increased binding of Rpl5 and Rpl11 to Mdm2 without a measured increase in their total abundance. Transfer of this interaction mechanism to patient cranial progenitors is inferred.
  evidence: &id003
  - reference: PMID:35881792
    reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
    explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
  downstream:
  - target: Reduced MDM2 Binding to p53
    description: Increased ribosomal-protein binding accompanies reduced Mdm2-p53 interaction. Competition is a supported interpretation of the co-immunoprecipitation pattern.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
      explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
- name: Reduced MDM2 Binding to p53
  biological_scale: MOLECULAR
  description: Mdm2-p53 co-immunoprecipitation decreases in the knockout fibroblast assay. Reduced degradation is the proposed consequence; the interaction experiment is not a patient-tissue degradation-rate measurement.
  evidence: *id003
  downstream:
  - target: Increased p53 Pathway Activity
    description: Reduced Mdm2 association provides a proposed stabilization mechanism that complements developmental p53-pathway observations.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: examination of cell-cycle inhibitor and p53 target gene p21 by qPCR demonstrated a significant increase in the NCCs of Polr1aNKO/NKO mutants
      explanation: A downstream p53 target increased in mutant neural crest cells; the p53 protein difference itself was not significant at this stage.
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
      explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
- name: Increased p53 Pathway Activity
  biological_scale: MOLECULAR
  description: Polr1a loss activates the p53 response in developmental models. Fish p53 assays and genetic inhibition support involvement. In mouse neural crest, p21 rises even though p53 protein elevation is not significant at the sampled stage.
  evidence:
  - reference: PMID:35881792
    reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: examination of cell-cycle inhibitor and p53 target gene p21 by qPCR demonstrated a significant increase in the NCCs of Polr1aNKO/NKO mutants
    explanation: A downstream p53 target increased in mutant neural crest cells; the p53 protein difference itself was not significant at this stage.
  - &id004
    reference: PMID:29750247
    reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype.
    explanation: Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.
  downstream:
  - target: Early Neuroepithelial and Neural Crest Apoptosis
    description: Genetic tp53 loss of function suppresses early fish neuroepithelial apoptosis, supporting a causal early component without preventing later cell death.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype.
      explanation: Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
- name: Early Neuroepithelial and Neural Crest Apoptosis
  biological_scale: CELLULAR
  description: Early neuroepithelial apoptosis in mutant fish reduces the source of cranial neural crest cells; mouse neural crest-restricted Polr1a loss also causes apoptosis. In fish, tp53 inhibition suppresses apoptosis at 24–48 hours but TUNEL labeling returns by 60 hours. Early protection is not permanent abolition of cell death.
  evidence:
  - *id004
  conforms_to: pol1_nucleolar_stress_neural_crest_apoptosis#p53-Dependent Neuroepithelial and Neural Crest Apoptosis
  cell_types:
  - preferred_term: neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  - preferred_term: neuroepithelial cell
    term:
      id: CL:0000710
      label: neurecto-epithelial cell
  biological_processes:
  - preferred_term: apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
    modifier: INCREASED
  downstream:
  - target: Depletion of Cranial Skeletal Precursors
    description: Early death reduces the population available to populate the pharyngeal arches; fish rescue restores early colonization, arguing against an intrinsic migration failure.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies.
      explanation: The fish model links early cell death with a smaller neural crest population.
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype.
      explanation: Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
- name: Reduced Neural Crest Cell Proliferation
  biological_scale: CELLULAR
  description: In the fish double-mutant experiment, arch neural crest proliferation remains about half of control at 36 hours despite tp53 inhibition. The earlier 24-hour reduction is not significant. This is a proliferation defect rather than proof of an intrinsic migration defect.
  evidence:
  - reference: PMID:29750247
    reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The percentage of proliferating neural crest cells in 36 hpf control embryos was 13.24% (n= 5), although inpolr1a–/–(n= 6) andpolr1a–/–;tp53–/–(n= 6) embryos it was 6.00% and 6.38%, respectively.
    explanation: The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.
  conforms_to: pol1_nucleolar_stress_neural_crest_apoptosis#p53-Independent Neural Crest Proliferation Failure
  cell_types:
  - preferred_term: neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  downstream:
  - target: Depletion of Cranial Skeletal Precursors
    description: Insufficient expansion may contribute to the residual cranial precursor deficit after transient protection from apoptosis.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: The percentage of proliferating neural crest cells in 36 hpf control embryos was 13.24% (n= 5), although inpolr1a–/–(n= 6) andpolr1a–/–;tp53–/–(n= 6) embryos it was 6.00% and 6.38%, respectively.
      explanation: The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.
    hypothesis_groups:
    - pol1_p53_independent_arm
- name: Depletion of Cranial Skeletal Precursors
  biological_scale: CELLULAR
  description: Loss and insufficient expansion of cranial neural crest-derived precursors reduce the population that forms craniofacial cartilage and bone. This mechanism does not directly explain mesoderm-derived limb malformations.
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies.
    explanation: The fish model links early cell death with a smaller neural crest population.
  conforms_to: pol1_nucleolar_stress_neural_crest_apoptosis#Depletion of Neural-Crest-Derived Craniofacial Skeletal Precursors
  cell_types:
  - preferred_term: neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  downstream:
  - target: Mandibulofacial Dysostosis
    description: Developmental models support reduced cranial precursor supply as a contributor to human craniofacial malformations, with unmeasured tissue and allele-specific intermediates.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies.
      explanation: The fish model links early cell death with a smaller neural crest population.
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1.
      explanation: Human cases establish the heterozygous POLR1A association.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
    - pol1_p53_independent_arm
  - target: Micrognathia
    description: Reduced precursor supply can contribute to mandibular hypoplasia; the experimental-to-human bridge is indirect.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies.
      explanation: The fish model links early cell death with a smaller neural crest population.
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1.
      explanation: Human cases establish the heterozygous POLR1A association.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
    - pol1_p53_independent_arm
  - target: Malar Hypoplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Experimental depletion of neural-crest-derived skeletal precursors provides a plausible route to zygomatic hypoplasia in the human spectrum. The human allele-specific mediator has not been directly measured.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: subtle craniofacial dysmorphism including malar hypoplasia, micrognathia, and dysplastic ears.
      explanation: Malar flattening or zygomatic hypoplasia contributes to the craniofacial phenotype.
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: resulting in a deficiency of neural-crest-derived skeletal precursor cells and consequently craniofacial anomalies.
      explanation: The fish model links early cell death with a smaller neural crest population.
    hypothesis_groups:
    - pol1_nucleolar_stress_ncc_apoptosis
    - pol1_p53_independent_arm
- name: Impaired Later Craniofacial Skeletogenesis
  biological_scale: TISSUE
  description: Ubiquitous R26-CreERT2 deletion of Polr1a induced at E9.0–9.5 and assessed at E12.5 reduces SOX9 signal and disrupts cartilage development. The timing spans late migration and post-migration. Relative transcriptomic cell proportions do not distinguish fate change from differential proliferation or survival.
  evidence: &id007
  - reference: PMID:41803115
    reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development.
    explanation: Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.
  downstream:
  - target: Reduced Craniofacial Skeletal Condensations
    description: The temporal knockout links Polr1a loss to smaller and discontinuous skeletal structures, without isolating the intervening cellular mechanism.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:41803115
      reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: Meckel’s cartilage, which manifested as two discrete non-contiguous proximal and distal elements
      explanation: The mutant mandible contains discontinuous Meckel cartilage.
    hypothesis_groups:
    - pol1_late_skeletogenesis
- name: Reduced Craniofacial Skeletal Condensations
  biological_scale: TISSUE
  description: Temporal Polr1a deletion reduces facial mesenchymal condensations and disrupts Meckel cartilage. Trigeminal ganglion volume is comparatively preserved. These observations do not establish normal neural function or absolute expansion of neuroglial cells.
  evidence:
  - reference: PMID:41803115
    reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected
    explanation: MicroCT identifies a preferential skeletal-condensation phenotype in the temporal mouse model.
  downstream:
  - target: Micrognathia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - pol1_late_skeletogenesis
    description: Reduced mandibular skeletogenesis and discontinuous Meckel cartilage in the temporal mouse knockout provide a plausible experimental route to mandibular hypoplasia. This does not demonstrate the mediator in heterozygous human patients.
    evidence:
    - reference: PMID:41803115
      reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected
      explanation: MicroCT identifies a preferential skeletal-condensation phenotype in the temporal mouse model.
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: severe micrognathia, which required tracheostomy at birth to establish a secure airway
      explanation: Mandibular hypoplasia ranges from mild to severe; the index infant required an airway intervention at birth.
phenotypes:
- name: Mandibulofacial Dysostosis
  category: Craniofacial
  description: Present in all three founding index cases, with marked variation in severity. The broader later cohort includes individuals without this full facial pattern.
  phenotype_term:
    preferred_term: Mandibulofacial dysostosis
    term:
      id: HP:0005321
      label: Mandibulofacial dysostosis
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: All three individuals exhibit varying degrees of mandibulofacial dysostosis, and two additionally have limb anomalies.
    explanation: Present in all three founding index cases, with marked variation in severity. The broader later cohort includes individuals without this full facial pattern.
- name: Micrognathia
  category: Craniofacial
  description: Mandibular hypoplasia ranges from mild to severe; the index infant required an airway intervention at birth.
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: severe micrognathia, which required tracheostomy at birth to establish a secure airway
    explanation: Mandibular hypoplasia ranges from mild to severe; the index infant required an airway intervention at birth.
- name: Malar Hypoplasia
  category: Craniofacial
  description: Malar flattening or zygomatic hypoplasia contributes to the craniofacial phenotype.
  phenotype_term:
    preferred_term: Malar flattening
    term:
      id: HP:0000272
      label: Malar flattening
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: subtle craniofacial dysmorphism including malar hypoplasia, micrognathia, and dysplastic ears.
    explanation: Malar flattening or zygomatic hypoplasia contributes to the craniofacial phenotype.
- name: Cleft Palate
  category: Craniofacial
  description: Cleft palate occurs in both severe craniofacial presentations and the broader 2023 series.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: ablepharon, absent zygoma, bilateral anotia, cleft palate, underdeveloped maxilla, micrognathia (severe)
    explanation: Cleft palate occurs in both severe craniofacial presentations and the broader 2023 series.
- name: Hypertelorism
  category: Craniofacial
  description: Widely spaced eyes can be a prominent finding even without severe mandibulofacial dysostosis.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She was noted to have hypertelorism, low-set ears, and micrognathia.
    explanation: The clinical supplement repeatedly describes hypertelorism in individual cases.
- name: Downslanted Palpebral Fissures
  category: Craniofacial
  description: Downslanting palpebral fissures were documented in the founding cases.
  phenotype_term:
    preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Initial physical exam of the full-term newborn revealed down-slanting palpebral fissures, severe bilateral lower eyelid clefts, inferiorly displaced orbits, an underdeveloped midface, and extreme micrognathia (Figures 1A–1C).
    explanation: Downslanting palpebral fissures were documented in the founding cases.
- name: Eyelid Coloboma
  category: Craniofacial
  description: Upper or lower eyelid clefts occur, with severe bilateral lower eyelid defects in the index infant.
  phenotype_term:
    preferred_term: Eyelid coloboma
    term:
      id: HP:0000625
      label: Eyelid coloboma
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 1A2, previously described by Wieczorek et al.,22 is a 6-year-old Brazilian female with craniofacial anomalies including short, down-slanting palpebral fissures, upper and lower eyelid clefts, absent medial eyelashes, heminasal aplasia, large ears, and full lips (Figure 2A).
    explanation: Upper or lower eyelid clefts occur, with severe bilateral lower eyelid defects in the index infant.
- name: Anotia
  category: Craniofacial
  description: Bilateral absence of external ears was documented in the severely affected index infant.
  phenotype_term:
    preferred_term: Anotia
    term:
      id: HP:0009892
      label: Anotia
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Bilateral anotia and severe conductive hearing loss were present. At birth, head circumference was 33 cm (−1.7 SDs), length was 43 cm (−4 SDs), and weight was 2.4 kg (−2.5 SDs).
    explanation: Bilateral absence of external ears was documented in the severely affected index infant.
- name: Microtia
  category: Craniofacial
  description: Unilateral microtia was recorded in the adult founding case.
  phenotype_term:
    preferred_term: Microtia
    term:
      id: HP:0008551
      label: Microtia
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: down-slanting palpebral fissures, malar flattening, unilateral microtia, micrognathia (mild)
    explanation: Unilateral microtia was recorded in the adult founding case.
- name: Conductive Hearing Impairment
  category: Audiologic
  description: Severe conductive hearing loss was directly observed in the index infant; conductive loss is also reported in the expanded cohort.
  phenotype_term:
    preferred_term: Conductive hearing impairment
    term:
      id: HP:0000405
      label: Conductive hearing impairment
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Bilateral anotia and severe conductive hearing loss were present. At birth, head circumference was 33 cm (−1.7 SDs), length was 43 cm (−4 SDs), and weight was 2.4 kg (−2.5 SDs).
    explanation: Severe conductive hearing loss was directly observed in the index infant; conductive loss is also reported in the expanded cohort.
- name: Sensorineural Hearing Impairment
  category: Audiologic
  description: Congenital sensorineural hearing loss was reported in individual 3 of the 2023 series, who carried a de novo early frameshift and had severe multisystem disease.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She was noted to have congenital moderate-to- severe sensorineural hearing loss in the newborn period and was admitted to intensive care at 6 weeks of age due to poor feeding, lethargy and respiratory distress.
    explanation: Congenital sensorineural hearing loss was reported in individual 3 of the 2023 series, who carried a de novo early frameshift and had severe multisystem disease.
- name: Choanal Atresia
  category: Craniofacial
  description: Bilateral choanal atresia occurred in the second founding case and choanal atresia was surgically treated in a later case.
  phenotype_term:
    preferred_term: Choanal atresia
    term:
      id: HP:0000453
      label: Choanal atresia
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: bilateral choanal atresia, upper and lower eyelid clefts, microcephaly
    explanation: Bilateral choanal atresia occurred in the second founding case and choanal atresia was surgically treated in a later case.
- name: Microcephaly
  category: Craniofacial
  description: Microcephaly is documented in some cases but head size is variable.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: bilateral choanal atresia, upper and lower eyelid clefts, microcephaly
    explanation: Microcephaly is documented in some cases but head size is variable.
- name: Metopic Craniosynostosis
  category: Craniofacial
  description: Metopic craniosynostosis was documented in the 2023 series, including the p.Asp59Val brothers and individual 14. It cannot be used as an exclusion criterion.
  phenotype_term:
    preferred_term: Metopic synostosis
    term:
      id: HP:0011330
      label: Metopic synostosis
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: He had bilateral cleft lip and palate, metopic craniosynostosis, and bilateral hydroceles.
    explanation: Metopic craniosynostosis was documented in the 2023 series, including the p.Asp59Val brothers and individual 14. It cannot be used as an exclusion criterion.
- name: Acalvaria
  category: Craniofacial
  description: Near-complete lack of calvarial ossification was documented in the p.Met496Ile infant; serial imaging showed progressive postnatal ossification. The 2023 and 2025 publications describe the same individual.
  phenotype_term:
    preferred_term: Absent ossification of calvaria
    term:
      id: HP:0005623
      label: Absent ossification of calvaria
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Head CT with 3D reconstruction of Individual 8 demonstrates (B) almost complete acalvaria at 3 days of age and (C) progressive post-natal ossification evident at 26 months of age.
    explanation: Near-complete lack of calvarial ossification was documented in the p.Met496Ile infant; serial imaging showed progressive postnatal ossification. The 2023 and 2025 publications describe the same individual.
- name: Short Stature
  category: Growth
  description: The founding index infant had severe short stature that became more pronounced by age three; stature is not uniformly reduced.
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Short stature became more significant with age
    explanation: The founding index infant had severe short stature that became more pronounced by age three; stature is not uniformly reduced.
- name: Femoral Bowing
  category: Skeletal
  description: Congenital short bowed femora were observed in the severe founding case.
  phenotype_term:
    preferred_term: Femoral bowing
    term:
      id: HP:0002980
      label: Femoral bowing
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses
    explanation: Congenital short bowed femora were observed in the severe founding case.
- name: Flared Metaphyses
  category: Skeletal
  description: Metaphyseal flaring accompanied bowed femora in the severe founding case.
  phenotype_term:
    preferred_term: Flared metaphysis
    term:
      id: HP:0003015
      label: Flared metaphysis
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses
    explanation: Metaphyseal flaring accompanied bowed femora in the severe founding case.
- name: Acetabular Dysplasia
  category: Skeletal
  description: Dysplastic acetabulae were documented in the severe founding case.
  phenotype_term:
    preferred_term: Acetabular dysplasia
    term:
      id: HP:0008807
      label: Acetabular dysplasia
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses
    explanation: Dysplastic acetabulae were documented in the severe founding case.
- name: Delayed Femoral Epiphyseal Ossification
  category: Skeletal
  description: Ossification of the capital femoral epiphyses was delayed or absent in the founding infant.
  phenotype_term:
    preferred_term: Delayed proximal femoral epiphyseal ossification
    term:
      id: HP:0008828
      label: Delayed proximal femoral epiphyseal ossification
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: In addition, individual 1A1 had congenital short bowed femurs with metaphyseal flaring, dysplastic acetabulae, and delayed or absent ossification of the capital femoral epiphyses (Figure 1F).
    explanation: Ossification of the capital femoral epiphyses was delayed or absent in the founding infant.
- name: Brachydactyly
  category: Skeletal
  description: Short broad fingers and toes were documented in the mildly affected adult founding case.
  phenotype_term:
    preferred_term: Brachydactyly
    term:
      id: HP:0001156
      label: Brachydactyly
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Short, broad fingers of individual IA3.
    explanation: Short broad fingers and toes were documented in the mildly affected adult founding case.
- name: Radial Aplasia
  category: Skeletal
  description: Unilateral radial aplasia was reported in individual 12 with an inherited truncating variant and normal reported development.
  phenotype_term:
    preferred_term: Unilateral radial aplasia
    term:
      id: HP:0011908
      label: Unilateral radial aplasia
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 12 is a 4.25-year-old male with multiple anomalies including left hemifacial microsomia, unilateral radial aplasia (left), several small ventricular septal defects, and pulmonary artery stenosis.
    explanation: Unilateral radial aplasia was reported in individual 12 with an inherited truncating variant and normal reported development.
- name: Preaxial Hand Polydactyly
  category: Skeletal
  description: Duplication of the right thumb was documented in individual 10 with a truncating variant.
  phenotype_term:
    preferred_term: Preaxial hand polydactyly
    term:
      id: HP:0001177
      label: Preaxial hand polydactyly
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: X-rays demonstrate duplication of the right thumb with bifid distal phalanx, short medial phalanx of the 5th fingers, radial hemimelia, as well as triphalangeal halluces.
    explanation: Duplication of the right thumb was documented in individual 10 with a truncating variant.
- name: Clubfoot
  category: Skeletal
  description: Clubfeet were documented in individual 10 alongside radial and thumb abnormalities.
  phenotype_term:
    preferred_term: Talipes equinovarus
    term:
      id: HP:0001762
      label: Talipes equinovarus
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At birth she was noted to have a posterior cleft palate, micrognathia, radial dysplasia, and club feet.
    explanation: Clubfeet were documented in individual 10 alongside radial and thumb abnormalities.
- name: Atrial Septal Defect
  category: Cardiovascular
  description: An atrial septal defect was reported in the p.Met496Ile infant.
  phenotype_term:
    preferred_term: Atrial septal defect
    term:
      id: HP:0001631
      label: Atrial septal defect
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis.
    explanation: An atrial septal defect was reported in the p.Met496Ile infant.
- name: Ventricular Septal Defect
  category: Cardiovascular
  description: Ventricular septal defects are documented in several individuals in the expanded series.
  phenotype_term:
    preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She had congenital unilateral vocal cord paralysis, short stature (147.5 cm), small HC (< 3rd) ptosis, subaortic ventricular septal defect, myopia, and hypotonia.
    explanation: Ventricular septal defects are documented in several individuals in the expanded series.
- name: Patent Ductus Arteriosus
  category: Cardiovascular
  description: Patent ductus arteriosus was recorded in the second founding case and in later reports.
  phenotype_term:
    preferred_term: Patent ductus arteriosus
    term:
      id: HP:0001643
      label: Patent ductus arteriosus
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Other | short stature | patent ductus arteriosus |
    explanation: Patent ductus arteriosus was recorded in the second founding case and in later reports.
- name: Hypertrophic Cardiomyopathy
  category: Cardiovascular
  description: Hypertrophic cardiomyopathy was documented in the severely affected infant with a de novo early frameshift; this is an individual observation.
  phenotype_term:
    preferred_term: Hypertrophic cardiomyopathy
    term:
      id: HP:0001639
      label: Hypertrophic cardiomyopathy
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She was found to have hypertrophic cardiomyopathy and elevated lactate.
    explanation: Hypertrophic cardiomyopathy was documented in the severely affected infant with a de novo early frameshift; this is an individual observation.
- name: Hydrocephalus
  category: Neurologic
  description: Hydrocephalus, including aqueductal stenosis in one case, occurred in the expanded cohort. Some patients underwent surgical treatment.
  phenotype_term:
    preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 'Individual 6 is a 10-year-old female with multiple congenital anomalies: choanal atresia requiring surgical repair, hydrocephalus with C0/C1 stenosis treated with ventriculocisternostomy, and cleft palate.'
    explanation: Hydrocephalus, including aqueductal stenosis in one case, occurred in the expanded cohort. Some patients underwent surgical treatment.
- name: Syringomyelia
  category: Neurologic
  description: Extensive syringomyelia was shown on MRI in individual 6.
  phenotype_term:
    preferred_term: Syringomyelia
    term:
      id: HP:0003396
      label: Syringomyelia
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: (A) MRI of individual 6 demonstrates extensive syringomyelia (Left) and ventriculomegaly (Right).
    explanation: Extensive syringomyelia was shown on MRI in individual 6.
- name: Hypotonia
  category: Neurologic
  description: Hypotonia is documented across several cases in the expanded series, particularly those with developmental impairment.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Physical exam was notable for microcephaly, congenital nevus on the scalp, hypotonia and micrognathia.
    explanation: Hypotonia is documented across several cases in the expanded series, particularly those with developmental impairment.
- name: Global Developmental Delay
  category: Developmental
  description: Some patients have severe motor and language delay, whereas other affected individuals have normal development. The p.Met496Ile infant also had neonatal ischemic injury, limiting attribution of all developmental findings to POLR1A.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At age 2 years, his development globally delayed. He was able to make sounds, laugh, roll over, sit with support, enjoy tastes by mouth, and bring items to midline and pass between his hands.
    explanation: Some patients have severe motor and language delay, whereas other affected individuals have normal development. The p.Met496Ile infant also had neonatal ischemic injury, limiting attribution of all developmental findings to POLR1A.
- name: Seizure
  category: Neurologic
  description: Epilepsy ranges from controlled focal seizures to early-onset drug-resistant seizures and infantile spasms. The 2023 cohort included a separate ATP1A1 diagnosis in one individual with severe epilepsy.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: His epilepsy has been refractive to multiple medications and he is currently on 5 antiepileptic medications (clobazam, topiramate, phenobarbital, brivaracetam,and rufinimide) having previously tried vigabatrin (ineffective), levetiracetam (behavioral problems), and lacosmide (ineffective).
    explanation: Epilepsy ranges from controlled focal seizures to early-onset drug-resistant seizures and infantile spasms. The 2023 cohort included a separate ATP1A1 diagnosis in one individual with severe epilepsy.
- name: Epileptic Encephalopathy
  category: Neurologic
  description: Individual 9 developed epileptic encephalopathy with regression after initially normal development; his truncating variant was also present in apparently unaffected relatives.
  phenotype_term:
    preferred_term: Epileptic encephalopathy
    term:
      id: HP:0200134
      label: Epileptic encephalopathy
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 9 is an almost 4-year-old male who developed epileptic encephalopathy at age 2.5 years.
    explanation: Individual 9 developed epileptic encephalopathy with regression after initially normal development; his truncating variant was also present in apparently unaffected relatives.
- name: Vocal Cord Paralysis
  category: Respiratory
  description: Unilateral or bilateral vocal cord paralysis occurred in a mother and child carrying p.Arg393His, classified as uncertain in their clinical report despite an abnormal transcription assay.
  phenotype_term:
    preferred_term: Vocal cord paralysis
    term:
      id: HP:0001605
      label: Vocal cord paralysis
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 4 is an 18-month-old male who presented to genetics for evaluation of bilateral vocal cord paralysis, feeding difficulties, and hypotonia.
    explanation: Unilateral or bilateral vocal cord paralysis occurred in a mother and child carrying p.Arg393His, classified as uncertain in their clinical report despite an abnormal transcription assay.
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Clinical trio exome sequencing (GeneDx, Gaithersburg, MD) identified a maternally inherited variant in POLR1A c.1178G>A; p.(Arg393His) and a maternally inherited variant in PHEX c.160T>C; p.(Cys54Arg) (NM_000444.6, GRCH 38), both variants of uncertain significance. Clinical SNP microarray was normal.
    explanation: The clinical report classified the inherited POLR1A and PHEX variants as uncertain.
- name: Failure to Thrive
  category: Growth
  description: Poor growth and feeding difficulties requiring enteral support are documented in several children.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 14 is a 6-month-old male with craniofacial anomalies, hypotonia, failure to thrive requiring gastrostomy tube placement, unilateral (left) cryptorchidism, right sided inguinal hernia, and developmental delay.
    explanation: Poor growth and feeding difficulties requiring enteral support are documented in several children.
- name: Cryptorchidism
  category: Genitourinary
  description: Cryptorchidism was documented in individual cases, including the p.Met496Ile infant.
  phenotype_term:
    preferred_term: Cryptorchidism
    term:
      id: HP:0000028
      label: Cryptorchidism
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis.
    explanation: Cryptorchidism was documented in individual cases, including the p.Met496Ile infant.
- name: Hydronephrosis
  category: Genitourinary
  description: Right hydronephrosis was documented in the p.Met496Ile infant; this is not an established high-frequency feature.
  phenotype_term:
    preferred_term: Hydronephrosis
    term:
      id: HP:0000126
      label: Hydronephrosis
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Additionally, he had bilateral cryptorchidism, an atrial septal defect, and right-sided hydronephrosis.
    explanation: Right hydronephrosis was documented in the p.Met496Ile infant; this is not an established high-frequency feature.
- name: Sleep Apnea
  category: Respiratory
  description: Mixed obstructive and central sleep apnea was documented in one p.Asp59Val brother.
  phenotype_term:
    preferred_term: Sleep apnea
    term:
      id: HP:0010535
      label: Sleep apnea
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen.
    explanation: Mixed obstructive and central sleep apnea was documented in one p.Asp59Val brother.
- name: Ptosis
  category: Craniofacial
  description: Ptosis occurs in several reported individuals, including those with relatively mild craniofacial abnormalities.
  phenotype_term:
    preferred_term: Ptosis
    term:
      id: HP:0000508
      label: Ptosis
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She had congenital unilateral vocal cord paralysis, short stature (147.5 cm), small HC (< 3rd) ptosis, subaortic ventricular septal defect, myopia, and hypotonia.
    explanation: Ptosis occurs in several reported individuals, including those with relatively mild craniofacial abnormalities.
- name: Cleft Lip
  category: Craniofacial
  description: Cleft lip accompanied cleft palate in the p.Asp59Val brothers.
  phenotype_term:
    preferred_term: Cleft upper lip
    term:
      id: HP:0000204
      label: Cleft upper lip
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: He had bilateral cleft lip and palate, metopic craniosynostosis, and bilateral hydroceles.
    explanation: Cleft lip accompanied cleft palate in the p.Asp59Val brothers.
- name: Lower Limb Spasticity
  category: Neurologic
  description: Lower-limb spasticity was documented with dystonia and motor delay in individual 11, whose reported cognition and brain MRI were normal.
  phenotype_term:
    preferred_term: Lower limb spasticity
    term:
      id: HP:0002061
      label: Lower limb spasticity
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
    explanation: Lower-limb spasticity was documented with dystonia and motor delay in individual 11, whose reported cognition and brain MRI were normal.
- name: Dystonia
  category: Neurologic
  description: Dystonia of the legs was reported in individual 11 with p.Val1241Ile. This is a case-specific observation.
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
    explanation: Dystonia of the legs was reported in individual 11 with p.Val1241Ile. This is a case-specific observation.
- name: Strabismus
  category: Ophthalmologic
  description: Strabismus was surgically corrected in individual 10.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Surgical procedures were performed to correct the cleft palate, as well as strabismus.
    explanation: Strabismus was surgically corrected in individual 10.
- name: Low-set Ears
  category: Craniofacial
  description: Low-set ears were recorded in several individuals in the expanded clinical series.
  phenotype_term:
    preferred_term: Low-set ears
    term:
      id: HP:0000369
      label: Low-set ears
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She was noted to have hypertelorism, low-set ears, and micrognathia. She had a normal echocardiogram.
    explanation: Low-set ears were recorded in several individuals in the expanded clinical series.
genetic:
- name: POLR1A
  notes: Heterozygous missense, truncating and in-frame variants are associated with a variable phenotype. De novo and inherited alleles are documented, including transmission from mildly affected or apparently unaffected parents. The 2023 cohort includes uncertain variants and relatives; it does not establish that every rare POLR1A variant is causal. Eight newly evaluated variants had increased, decreased or unchanged rRNA transcription in engineered HCT116 cells. p.Glu593Gln has a dominant-negative effect in an overexpression assay, but this does not generalize to all alleles. p.Pro1638Leu had no detectable transcription phenotype and corresponding mice were normal, leaving its clinical contribution uncertain. The p.Met496Ile cell assay showed a mild increase, whereas the 2025 structural analysis proposed impaired interactions computationally; the latter is not a measured decrease in transcription.
  gene_term:
    preferred_term: POLR1A
    term:
      id: hgnc:17264
      label: POLR1A
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1.
    explanation: The founding report identifies heterozygous POLR1A variants.
  - *id005
  - *id006
  - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: p.Pro1638Leu, and p.Val1631Met (no change in transcrip- tion), and p.Val1241Ile and p.Met496Ile (mild increase in transcription)
    explanation: Different alleles do not share one biochemical direction.
progression:
- phase: Prenatal and neonatal structural disease
  notes: Severe craniofacial malformations may be detected prenatally and cause airway compromise at birth. Other children have milder facial findings with normal development. Severe infantile cardiorespiratory disease and early deaths occur in individual cases, without a reliable survival estimate.
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: severe micrognathia, which required tracheostomy at birth to establish a secure airway
    explanation: The severe index case required neonatal airway protection.
- phase: Variable childhood neurodevelopment
  notes: Development ranges from normal to severe impairment with epilepsy. One child developed epileptic encephalopathy and regression after initially normal development. This is not evidence of a universal progressive neurodegenerative course.
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 9 is an almost 4-year-old male who developed epileptic encephalopathy at age 2.5 years.
    explanation: Later-onset epilepsy with regression is a case-specific trajectory.
animal_models:
- name: polr1a mutant zebrafish with genetic tp53 suppression
  species: Zebrafish
  genotype: Homozygous polr1a hi3639Tg, with or without homozygous tp53 M214K
  description: The homozygous insertional mutant models reduced Polr1a function. tp53 M214K produces nonfunctional DNA-binding-domain protein; the paper abbreviates this as tp53 knockout, but it is not a genomic deletion. Early apoptosis and morphology improve, while later cartilage development and survival remain abnormal. Some double mutants survive to eight rather than five days. This dose and developmental timing differ from heterozygous human disease.
  publication: PMID:29750247
  modeled_mechanisms:
  - target: Reduced Pol I rRNA Transcription
    relationship: MEASURES
    fidelity: MODERATE
    description: Precursor-rRNA spacer abundance falls in the mutant and is not restored by tp53 inhibition.
    limitations: RT-qPCR is a transcription proxy. Mature 18S RNA is unchanged at 24 hours but decreases at 48 hours; residual rRNA remains.
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
      explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
    readouts:
    - name: Precursor-rRNA or nascent nucleolar RNA signal
      target: Reduced Pol I rRNA Transcription
      direction: DECREASED
      interpretation: Precursor-rRNA spacer abundance falls in the mutant and is not restored by tp53 inhibition.
      evidence:
      - reference: PMID:29750247
        reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
        explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
  - target: Reduced Ribosome Availability
    relationship: MEASURES
    fidelity: MODERATE
    description: Monosome and polysome profiles decrease.
    limitations: Polysome profiling used pooled whole embryos at three days, not purified neural crest cells.
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
      explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
    readouts:
    - name: Monosome and polysome abundance
      target: Reduced Ribosome Availability
      direction: DECREASED
      interpretation: Monosome and polysome profiles decrease.
      evidence:
      - reference: PMID:29750247
        reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: polr1a-/- mutants exhibit deficient 47S rRNA transcription, reduced monosomes and polysomes and, consequently, defects in protein translation
        explanation: Fish mutant assays distinguish precursor-rRNA, ribosome profiles and translation readouts.
  - target: Reduced Protein Translation
    relationship: MEASURES
    fidelity: MODERATE
    description: Radiolabeled methionine incorporation measures reduced protein synthesis.
    limitations: The assay used dissociated cells from whole embryos at 24 hours and did not demonstrate neural crest-specific translation or translation rescue in the double mutant.
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Consistent with these ideas, we confirmed through35S-Met incorporation that there was indeed a significant 75% reduction in protein synthesis inpolr1a–/–mutant zebrafish compared with controls (Fig.
      explanation: Radiolabeled methionine incorporation was measured in cells dissociated from 24-hour embryos, not isolated neural crest cells.
    readouts:
    - name: Radiolabeled methionine incorporation
      target: Reduced Protein Translation
      direction: DECREASED
      interpretation: Radiolabeled methionine incorporation measures reduced protein synthesis.
      evidence:
      - reference: PMID:29750247
        reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: Consistent with these ideas, we confirmed through35S-Met incorporation that there was indeed a significant 75% reduction in protein synthesis inpolr1a–/–mutant zebrafish compared with controls (Fig.
        explanation: Radiolabeled methionine incorporation was measured in cells dissociated from 24-hour embryos, not isolated neural crest cells.
  - target: Early Neuroepithelial and Neural Crest Apoptosis
    relationship: RESCUES
    fidelity: MODERATE
    description: tp53 M214K suppresses early neuroepithelial TUNEL labeling.
    limitations: 'Protection is temporary: apoptosis approaches controls at 24–48 hours but recurs by 60 hours. Cartilage rescue is partial.'
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype.
      explanation: Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: TUNEL positive cells were observed at 60 hpf inpolr1a–/–;tp53–/–embryos, at levels which were comparable topolr1a–/–embryos
      explanation: Apoptosis recurs after the early period of suppression.
    readouts:
    - name: Early TUNEL-positive cell abundance after tp53 suppression
      target: Early Neuroepithelial and Neural Crest Apoptosis
      direction: DECREASED
      interpretation: tp53 M214K suppresses early neuroepithelial TUNEL labeling.
      evidence:
      - reference: PMID:29750247
        reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: Tp53 inhibition suppresses neuroepithelial apoptosis and partially ameliorates the polr1a mutant phenotype.
        explanation: Genetic tp53 inhibition suppresses early apoptosis, but later cell death recurs and skeletal rescue remains incomplete.
      - reference: PMID:29750247
        reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: TUNEL positive cells were observed at 60 hpf inpolr1a–/–;tp53–/–embryos, at levels which were comparable topolr1a–/–embryos
        explanation: Apoptosis recurs after the early period of suppression.
  - target: Reduced Neural Crest Cell Proliferation
    relationship: MEASURES
    fidelity: MODERATE
    description: Arch neural crest proliferation remains reduced at 36 hours in both mutant backgrounds.
    limitations: The 24-hour comparison is not significant. Global proliferation improves with tp53 suppression, so the residual effect is not universal to all cells.
    evidence:
    - reference: PMID:29750247
      reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The percentage of proliferating neural crest cells in 36 hpf control embryos was 13.24% (n= 5), although inpolr1a–/–(n= 6) andpolr1a–/–;tp53–/–(n= 6) embryos it was 6.00% and 6.38%, respectively.
      explanation: The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.
    readouts:
    - name: Proliferating arch neural crest cell fraction
      target: Reduced Neural Crest Cell Proliferation
      direction: DECREASED
      interpretation: Arch neural crest proliferation remains reduced at 36 hours in both mutant backgrounds.
      evidence:
      - reference: PMID:29750247
        reference_title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: The percentage of proliferating neural crest cells in 36 hpf control embryos was 13.24% (n= 5), although inpolr1a–/–(n= 6) andpolr1a–/–;tp53–/–(n= 6) embryos it was 6.00% and 6.38%, respectively.
        explanation: The fish study directly measures persistent reduced arch neural crest proliferation at 36 hours after fertilization despite tp53 inhibition.
- name: Early neural crest-restricted Polr1a deletion in mouse
  species: Mouse
  genotype: Polr1a conditional loss with Wnt1-Cre; related Sox10-Cre null and C1559F models
  description: Early neural crest-restricted deletion produces severe craniofacial malformations and cell loss. Wnt1-Cre affects earlier progenitors than Sox10-Cre. C1559F with conditional removal of the other allele is less severe and shows later apoptosis than the null; it is not the same genotype as a human heterozygote.
  publication: PMID:35881792
  modeled_mechanisms:
  - target: Reduced Pol I rRNA Transcription
    relationship: MEASURES
    fidelity: MODERATE
    description: Sorted neural crest cells have reduced precursor-rRNA signal.
    limitations: Total protein measured by silver staining is not a direct translation-rate assay in these mutants.
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: qPCR for the 5′ETS region of rRNA is significantly reduced in the sorted NCCs of Polr1aNKO/NKO and Tcof1NKO/NKO embryos
      explanation: The precursor-rRNA measurement is directly in sorted mouse neural crest cells.
    readouts:
    - name: Precursor-rRNA or nascent nucleolar RNA signal
      target: Reduced Pol I rRNA Transcription
      direction: DECREASED
      interpretation: Sorted neural crest cells have reduced precursor-rRNA signal.
      evidence:
      - reference: PMID:35881792
        reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: qPCR for the 5′ETS region of rRNA is significantly reduced in the sorted NCCs of Polr1aNKO/NKO and Tcof1NKO/NKO embryos
        explanation: The precursor-rRNA measurement is directly in sorted mouse neural crest cells.
  - target: Early Neuroepithelial and Neural Crest Apoptosis
    relationship: RESCUES
    fidelity: MODERATE
    description: Neural crest loss contributes to craniofacial hypoplasia; p53 inhibition improves early arch development.
    limitations: Pifithrin-alpha was tested in embryo culture; three of four treated mutants had larger arches, but survival beyond E12.5 was not rescued. This is not patient treatment evidence.
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: showed a considerable increase in the volume of the pharyngeal arches in concert with increased YFP+ cells in the arches and frontonasal prominences (n = 3/4)
      explanation: Pharmacologic rescue was partial and measured in embryonic culture.
- name: Anterior heart-field conditional Polr1a deletion
  species: Mouse
  genotype: Polr1a null/flox; Mef2c-AHF-Cre
  description: Anterior heart-field deletion causes an underdeveloped right ventricle, shortened outflow tract and a large ventricular septal defect. A focal CC3 increase was observed but the quantified apoptosis comparison was not significant.
  publication: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
  modeled_mechanisms:
  - target: Ventricular Septal Defect
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: Conditional Polr1a loss produces a ventricular septal defect in the embryo.
    limitations: This tissue-restricted complete-loss model differs from a heterozygous human allele and does not establish apoptosis as the necessary mediator.
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Mef2c-AHF-Cre mutants have an under- developed right ventricle and large ventricular septal defect
      explanation: The model directly measures structural cardiac malformation.
- name: Forebrain conditional Polr1a loss and C1559F
  species: Mouse
  genotype: Polr1a null/flox or C1559F/flox; Foxg1-Cre
  description: Both genotypes produce a hypoplastic telencephalon, with greater anatomical severity in the null. At the sampled stage, CC3 elevation is significant in C1559F but not the null; bulk RNA findings also differ by allele.
  publication: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
  modeled_mechanisms:
  - target: Heterozygous POLR1A Variants
    relationship: PERTURBS
    fidelity: LOW
    description: Orthologous Polr1a manipulation tests the developmental requirement in forebrain progenitors.
    limitations: The experimental genotypes are conditional null or variant-only in the targeted lineage, rather than a patient heterozygote. Brain morphology is measured; human cognition, epilepsy and a uniform apoptosis sequence are not.
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the data demonstrate hypoplastic telen- cephalons in both mutants compared to controls
      explanation: Both conditional genotypes alter forebrain development.
- name: Polr1a germline variant knock-in mice
  species: Mouse
  genotype: C1559F and P1635L, orthologous to human C1562F and P1638L; additional A1632V/P1635L line
  description: Heterozygotes are healthy and fertile. Homozygous C1559F is embryonic lethal before E7, whereas P1635L homozygotes and P1635L/null animals have normal measured phenotypes. An additional humanized adjacent-residue line also lacks the proposed phenotype.
  publication: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
  modeled_mechanisms:
  - target: Heterozygous POLR1A Variants
    relationship: PERTURBS
    fidelity: LOW
    description: Knock-in models compare the effects of specific orthologous variants.
    limitations: Negative P1635L transcription and mouse results weaken attribution of individual 18’s findings to p.Pro1638Leu. Normal heterozygous mice and severe homozygous phenotypes prevent treating either line as a complete human phenocopy.
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Polr1aP1635L/null adult animals in the expected Mendelian ratios and with normal phenotypes
      explanation: P1635L is tolerated even in trans with a null allele.
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: No Polr1a C1559F/C1559F embryos were found (n ¼ 33 embryos, Table S4 ), consistent with data for homozygous null embryos.
      explanation: Homozygous C1559F is incompatible with the tested embryonic stages.
- name: Late migratory and post-migratory temporal Polr1a deletion
  species: Mouse
  genotype: Polr1a flox/flox; R26-CreERT2, tamoxifen at E9.0–9.5
  description: Ubiquitous temporal recombination is followed by analysis at E12.5. This is not a neural crest-restricted deletion. Single-cell data show mixed relative cell-type shifts; microCT and SOX9 labeling show preferential disruption of facial skeletal structures.
  publication: PMID:41803115
  modeled_mechanisms:
  - target: Impaired Later Craniofacial Skeletogenesis
    relationship: MEASURES
    fidelity: MODERATE
    description: SOX9 signal and cartilage development decrease after temporal deletion.
    limitations: Neither apoptosis nor proliferation was directly assayed in these developmental mutants, so fate conversion cannot be distinguished from survival or expansion. No heterozygous human variant was tested.
    evidence:
    - reference: PMID:41803115
      reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development.
      explanation: Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.
    readouts:
    - name: Mandibular SOX9 signal
      target: Impaired Later Craniofacial Skeletogenesis
      direction: DECREASED
      interpretation: SOX9 signal and cartilage development decrease after temporal deletion.
      evidence:
      - reference: PMID:41803115
        reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: mutant embryos exhibited reduced SOX9 signal in the mandible, consistent with diminished cartilage development.
        explanation: Temporal ubiquitous Polr1a deletion reduces a skeletogenic marker in the embryonic mandible.
  - target: Reduced Craniofacial Skeletal Condensations
    relationship: MEASURES
    fidelity: MODERATE
    description: Facial condensations decrease and Meckel cartilage becomes discontinuous.
    limitations: Relative preservation of trigeminal ganglion volume does not establish normal neural function or absolute neuroglial expansion.
    evidence:
    - reference: PMID:41803115
      reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected
      explanation: The structural comparison demonstrates different tissue sensitivity.
    readouts:
    - name: Facial mesenchymal condensation volume
      target: Reduced Craniofacial Skeletal Condensations
      direction: DECREASED
      interpretation: Facial condensations decrease and Meckel cartilage becomes discontinuous.
      evidence:
      - reference: PMID:41803115
        reference_title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: whereas Polr1aflx/flx;R26-Cre-ERT2 embryos exhibited reduced facial mesenchymal condensations, the trigeminal ganglia were not significantly affected
        explanation: The structural comparison demonstrates different tissue sensitivity.
experimental_models:
- name: Human POLR1A variant replacement in HCT116 cells
  experimental_model_type: CELL_LINE
  cell_source: Engineered HCT116 cells with auxin-degradable endogenous POLR1A and transient HaloTag-POLR1A constructs
  publication: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
  description: Endogenous POLR1A was degraded and variant constructs were tested for nascent nucleolar RNA and localization. This is an engineered cancer-cell assay rather than a patient-derived heterozygous neural crest model.
  modeled_mechanisms:
  - target: Reduced Pol I rRNA Transcription
    relationship: MEASURES
    fidelity: MODERATE
    description: p.Arg393His and p.Glu593Gln reduce nucleolar RNA synthesis.
    limitations: Construct replacement and normalization to HaloTag intensity do not reproduce endogenous heterozygous dosage; no universal disease-wide activity deficit follows.
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type
      explanation: Engineered HCT116 cells show lower rRNA synthesis for these two alleles.
    readouts:
    - name: Precursor-rRNA or nascent nucleolar RNA signal
      target: Reduced Pol I rRNA Transcription
      direction: DECREASED
      interpretation: p.Arg393His and p.Glu593Gln reduce nucleolar RNA synthesis.
      evidence:
      - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
        reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: The third group includes p.(Arg393His) and p.Glu593Gln, both of which demonstrated reduced transcription compared to wild type
        explanation: Engineered HCT116 cells show lower rRNA synthesis for these two alleles.
  - target: Increased Pol I rRNA Transcription
    relationship: MEASURES
    fidelity: MODERATE
    description: p.Asp59Val, p.Glu1330del and p.Cys1562Phe increase the RNA signal; two other alleles increase it mildly.
    limitations: p.Pro1638Leu and p.Val1631Met show no change. Effects do not consistently predict clinical severity or organ involvement.
    evidence:
    - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del.
      explanation: These alleles increase nascent nucleolar RNA in the engineered cell assay.
    readouts:
    - name: Nascent nucleolar RNA signal
      target: Increased Pol I rRNA Transcription
      direction: INCREASED
      interpretation: p.Asp59Val, p.Glu1330del and p.Cys1562Phe increase the RNA signal; two other alleles increase it mildly.
      evidence:
      - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
        reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: Increased rRNA synthesis was clearly observed with expression of variants encoding POLR1A p.As- p59Val, p.Cys1562Phe, and p.Glu1330del.
        explanation: These alleles increase nascent nucleolar RNA in the engineered cell assay.
- name: Inducible POLR1A p.Glu593Gln in HeLa cells
  experimental_model_type: CELL_LINE
  cell_source: HeLa S3 cells with tagged endogenous polymerase and inducible mutant expression
  publication: PMID:33055158
  description: Mutant expression at approximately twice the endogenous level produces abnormal condensates containing wild-type polymerase and suppresses nascent RNA and precursor rRNA. Tracking data support a dominant-negative interference model.
  modeled_mechanisms:
  - target: Abnormal Pol I Condensate Formation
    relationship: MEASURES
    fidelity: MODERATE
    description: Mutant and wild-type polymerase relocalize to abnormal condensates.
    limitations: Stable rDNA association and competition are inferred from tracking and localization; the experiment is not a patient neural crest assay.
    evidence:
    - reference: PMID:33055158
      reference_title: Transcriptional suppression of ribosomal DNA with phase separation.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Not only the mutant but also the WT Pol I was localized to the condensates (HaloTag-WT RPA194; Fig. 4A), suggesting that mutant Pol I compromised the stable Pol I cluster.
      explanation: Mutant and wild-type polymerase relocalize in an inducible HeLa overexpression experiment.
  - target: Reduced Pol I rRNA Transcription
    relationship: MEASURES
    fidelity: MODERATE
    description: 47S precursor rRNA decreases markedly after mutant induction.
    limitations: The reported 30% value is cellular transcript abundance relative to controls, not residual activity of purified patient enzyme.
    evidence:
    - reference: PMID:33055158
      reference_title: Transcriptional suppression of ribosomal DNA with phase separation.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the 47S pre-rRNA transcript was decreased to 30% in cells expressing RPA194-E593Q compared with control cells
      explanation: Precursor-rRNA output decreases in the induced cell model.
    readouts:
    - name: Precursor-rRNA or nascent nucleolar RNA signal
      target: Reduced Pol I rRNA Transcription
      direction: DECREASED
      interpretation: 47S precursor rRNA decreases markedly after mutant induction.
      evidence:
      - reference: PMID:33055158
        reference_title: Transcriptional suppression of ribosomal DNA with phase separation.
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: the 47S pre-rRNA transcript was decreased to 30% in cells expressing RPA194-E593Q compared with control cells
        explanation: Precursor-rRNA output decreases in the induced cell model.
- name: Tamoxifen-induced Polr1a deletion in mouse embryonic fibroblasts
  experimental_model_type: PRIMARY_CELL_CULTURE
  cell_source: Mouse embryonic fibroblasts with inducible CreERT2 deletion
  publication: PMID:35881792
  description: Co-immunoprecipitation examines the ribosomal-protein/Mdm2/p53 interaction mechanism in cultured fibroblasts. Parallel Polr1c and Tcof1 manipulations support a shared pathway but are not additional human POLR1A alleles.
  modeled_mechanisms:
  - target: Increased RPL5 and RPL11 Binding to MDM2
    relationship: MEASURES
    fidelity: MODERATE
    description: Rpl5 and Rpl11 binding to Mdm2 increases.
    limitations: Total abundance of the assayed proteins was unchanged. The proposed free-ribosomal-protein imbalance was not directly quantified in patient neural crest.
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
      explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
    readouts:
    - name: MDM2-associated RPL5 and RPL11 abundance
      target: Increased RPL5 and RPL11 Binding to MDM2
      direction: INCREASED
      interpretation: Rpl5 and Rpl11 binding to Mdm2 increases.
      evidence:
      - reference: PMID:35881792
        reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
        explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
  - target: Reduced MDM2 Binding to p53
    relationship: MEASURES
    fidelity: MODERATE
    description: Mdm2-p53 co-immunoprecipitation decreases.
    limitations: This interaction readout does not directly measure the rate of p53 degradation in an embryo.
    evidence:
    - reference: PMID:35881792
      reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
      explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
    readouts:
    - name: MDM2-associated p53 abundance
      target: Reduced MDM2 Binding to p53
      direction: DECREASED
      interpretation: Mdm2-p53 co-immunoprecipitation decreases.
      evidence:
      - reference: PMID:35881792
        reference_title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
        supports: SUPPORT
        evidence_source: IN_VITRO
        quote_role: PRIMARY_RESULT
        directness: DIRECT
        snippet: immunoprecipitation followed by immunoblotting revealed increased binding of Rpl5 and Rpl11 to Mdm2, in concert with decreased binding between Mdm2 and p53 in tKO MEFs compared with controls
        explanation: Tamoxifen-induced deletion in mouse embryonic fibroblasts altered co-immunoprecipitated interactions.
treatments:
- name: Airway stabilization and tracheostomy
  description: Severe micrognathia can require tracheostomy at birth. A later child with vocal cord paralysis also required tracheostomy. These are reported interventions for individual anatomy and airway compromise.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Tracheotomy
    term:
      id: NCIT:C15341
      label: Tracheotomy
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: severe micrognathia, which required tracheostomy at birth to establish a secure airway
    explanation: Severe micrognathia can require tracheostomy at birth. A later child with vocal cord paralysis also required tracheostomy. These are reported interventions for individual anatomy and airway compromise.
  target_phenotypes:
  - preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  - preferred_term: Vocal cord paralysis
    term:
      id: HP:0001605
      label: Vocal cord paralysis
  target_mechanisms:
  - target: Micrognathia
    treatment_effect: BYPASSES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: severe micrognathia, which required tracheostomy at birth to establish a secure airway
      explanation: Severe micrognathia can require tracheostomy at birth. A later child with vocal cord paralysis also required tracheostomy. These are reported interventions for individual anatomy and airway compromise.
  - target: Vocal Cord Paralysis
    treatment_effect: BYPASSES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: PMID:25913037
      reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: severe micrognathia, which required tracheostomy at birth to establish a secure airway
      explanation: Severe micrognathia can require tracheostomy at birth. A later child with vocal cord paralysis also required tracheostomy. These are reported interventions for individual anatomy and airway compromise.
- name: Gastrostomy feeding
  description: Gastrostomy was used for aspiration, poor feeding or failure to thrive in several children. Case reports establish its use without comparative outcome estimates.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Gastrostomy
    term:
      id: NCIT:C52006
      label: Gastrostomy
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: he was diagnosed with frank aspiration, requiring gastrostomy tube placement.
    explanation: Gastrostomy was used for aspiration, poor feeding or failure to thrive in several children. Case reports establish its use without comparative outcome estimates.
  target_phenotypes:
  - preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  target_mechanisms:
  - target: Failure to Thrive
    treatment_effect: BYPASSES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: he was diagnosed with frank aspiration, requiring gastrostomy tube placement.
      explanation: Gastrostomy was used for aspiration, poor feeding or failure to thrive in several children. Case reports establish its use without comparative outcome estimates.
- name: Craniofacial reconstructive surgery
  description: Cleft palate and strabismus correction, choanal surgery and craniosynostosis procedures have been used according to the individual malformation. The reports do not provide a standardized operative schedule or comparative benefit.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Reconstructive Surgery
    term:
      id: NCIT:C25351
      label: Reconstructive Surgery
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Surgical procedures were performed to correct the cleft palate, as well as strabismus.
    explanation: Cleft palate and strabismus correction, choanal surgery and craniosynostosis procedures have been used according to the individual malformation. The reports do not provide a standardized operative schedule or comparative benefit.
  target_phenotypes:
  - preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  - preferred_term: Choanal atresia
    term:
      id: HP:0000453
      label: Choanal atresia
  - preferred_term: Metopic synostosis
    term:
      id: HP:0011330
      label: Metopic synostosis
  target_mechanisms:
  - target: Cleft Palate
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Surgical procedures were performed to correct the cleft palate, as well as strabismus.
      explanation: Cleft palate and strabismus correction, choanal surgery and craniosynostosis procedures have been used according to the individual malformation. The reports do not provide a standardized operative schedule or comparative benefit.
  - target: Choanal Atresia
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Surgical procedures were performed to correct the cleft palate, as well as strabismus.
      explanation: Cleft palate and strabismus correction, choanal surgery and craniosynostosis procedures have been used according to the individual malformation. The reports do not provide a standardized operative schedule or comparative benefit.
  - target: Metopic Craniosynostosis
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Surgical procedures were performed to correct the cleft palate, as well as strabismus.
      explanation: Cleft palate and strabismus correction, choanal surgery and craniosynostosis procedures have been used according to the individual malformation. The reports do not provide a standardized operative schedule or comparative benefit.
- name: Antiseizure medication
  description: Antiseizure medicines are used for clinical epilepsy, with variable response. Some cases require multiple agents, whereas the child with p.Val1631Met had epilepsy controlled on lamotrigine; that allele showed no transcription change in the reported assay.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Anticonvulsant Therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She has generalized epilepsy well controlled on lamotrigine. She required a gastrostomy tube for poor feeding.
    explanation: Antiseizure medicines are used for clinical epilepsy, with variable response. Some cases require multiple agents, whereas the child with p.Val1631Met had epilepsy controlled on lamotrigine; that allele showed no transcription change in the reported assay.
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  target_mechanisms:
  - target: Seizure
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: She has generalized epilepsy well controlled on lamotrigine. She required a gastrostomy tube for poor feeding.
      explanation: Antiseizure medicines are used for clinical epilepsy, with variable response. Some cases require multiple agents, whereas the child with p.Val1631Met had epilepsy controlled on lamotrigine; that allele showed no transcription change in the reported assay.
- name: Supplemental oxygen for sleep apnea
  description: One child with mixed obstructive and central apnea received supplemental oxygen after polysomnography. This is a case-specific intervention rather than a general sleep-apnea regimen.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Oxygen Therapy
    term:
      id: NCIT:C94624
      label: Oxygen Therapy
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen. At 4 months of age, his weight gain plateaued, and he was diagnosed with frank aspiration, requiring gastrostomy tube placement.
    explanation: One child with mixed obstructive and central apnea received supplemental oxygen after polysomnography. This is a case-specific intervention rather than a general sleep-apnea regimen.
  target_phenotypes:
  - preferred_term: Sleep apnea
    term:
      id: HP:0010535
      label: Sleep apnea
  target_mechanisms:
  - target: Sleep Apnea
    treatment_effect: BYPASSES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen. At 4 months of age, his weight gain plateaued, and he was diagnosed with frank aspiration, requiring gastrostomy tube placement.
      explanation: One child with mixed obstructive and central apnea received supplemental oxygen after polysomnography. This is a case-specific intervention rather than a general sleep-apnea regimen.
- name: Surgical treatment of hydrocephalus
  description: Hydrocephalus was treated with ventriculocisternostomy in one child and shunting in another. Care depends on the structural cause and clinical assessment.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Ventriculostomy
    term:
      id: NCIT:C99771
      label: Ventriculostomy
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 'Individual 6 is a 10-year-old female with multiple congenital anomalies: choanal atresia requiring surgical repair, hydrocephalus with C0/C1 stenosis treated with ventriculocisternostomy, and cleft palate.'
    explanation: Hydrocephalus was treated with ventriculocisternostomy in one child and shunting in another. Care depends on the structural cause and clinical assessment.
  target_phenotypes:
  - preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  target_mechanisms:
  - target: Hydrocephalus
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: 'Individual 6 is a 10-year-old female with multiple congenital anomalies: choanal atresia requiring surgical repair, hydrocephalus with C0/C1 stenosis treated with ventriculocisternostomy, and cleft palate.'
      explanation: Hydrocephalus was treated with ventriculocisternostomy in one child and shunting in another. Care depends on the structural cause and clinical assessment.
- name: Orthopedic surgery
  description: Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Orthopedic Surgical Procedure
    term:
      id: NCIT:C16186
      label: Orthopedic Surgical Procedure
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
    explanation: Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.
  target_phenotypes:
  - preferred_term: Lower limb spasticity
    term:
      id: HP:0002061
      label: Lower limb spasticity
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  target_mechanisms:
  - target: Lower Limb Spasticity
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
      explanation: Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.
  - target: Dystonia
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Individual 11 is an 11-year-old male with mild hypertelorism, gross motor delay, and spastic dystonia of the legs requiring tendon surgery. Otherwise, he had no intellectual problems and attends normal school.
      explanation: Tendon surgery was reported for lower-limb spastic dystonia in an individual with p.Val1241Ile. This single case does not establish a general orthopedic treatment schedule.
- name: Individualized cardiac surgery
  description: Cardiac repair was reported in individual 18 with complex defects, but the contribution of p.Pro1638Leu to that phenotype is uncertain after negative functional and mouse findings. Surgical use in that case must not be interpreted as evidence of a POLR1A-specific treatment effect.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Cardiovascular Surgical Procedure
    term:
      id: NCIT:C49803
      label: Cardiovascular Surgical Procedure
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Septal defects and mitral valve also required surgical repair. She had bilateral hip replacement at age 14 due to severe pain related to osteoarthritis and acetabular protrusion.
    explanation: Cardiac repair was reported in individual 18 with complex defects, but the contribution of p.Pro1638Leu to that phenotype is uncertain after negative functional and mouse findings. Surgical use in that case must not be interpreted as evidence of a POLR1A-specific treatment effect.
  target_phenotypes:
  - preferred_term: Atrial septal defect
    term:
      id: HP:0001631
      label: Atrial septal defect
  - preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  target_mechanisms:
  - target: Atrial Septal Defect
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Septal defects and mitral valve also required surgical repair. She had bilateral hip replacement at age 14 due to severe pain related to osteoarthritis and acetabular protrusion.
      explanation: Cardiac repair was reported in individual 18 with complex defects, but the contribution of p.Pro1638Leu to that phenotype is uncertain after negative functional and mouse findings. Surgical use in that case must not be interpreted as evidence of a POLR1A-specific treatment effect.
  - target: Ventricular Septal Defect
    treatment_effect: MODULATES
    description: Symptom-directed intervention for this reported manifestation; no correction of POLR1A biology is claimed.
    evidence:
    - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Septal defects and mitral valve also required surgical repair. She had bilateral hip replacement at age 14 due to severe pain related to osteoarthritis and acetabular protrusion.
      explanation: Cardiac repair was reported in individual 18 with complex defects, but the contribution of p.Pro1638Leu to that phenotype is uncertain after negative functional and mouse findings. Surgical use in that case must not be interpreted as evidence of a POLR1A-specific treatment effect.
- name: Mandibular distraction in a reported case
  description: Mandibular distraction at age seven was reported in individual 18 carrying p.Pro1638Leu. That allele had negative functional and mouse findings, so this is an intervention in a reported, etiologically uncertain case, not evidence of a POLR1A-specific treatment effect.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Reconstructive Surgery
    term:
      id: NCIT:C25351
      label: Reconstructive Surgery
  target_phenotypes:
  - preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Micrognathia was treated with mandibular distraction at age 7
    explanation: Mandibular distraction at age seven was reported in individual 18 carrying p.Pro1638Leu. That allele had negative functional and mouse findings, so this is an intervention in a reported, etiologically uncertain case, not evidence of a POLR1A-specific treatment effect.
diagnosis:
- name: Molecular genetic testing
  diagnosis_term:
    preferred_term: Whole Exome Sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  description: Exome or genome sequencing can identify heterozygous POLR1A variants in patients with craniofacial malformations, limb defects or a broader neurodevelopmental presentation. Variant classification, parental testing and clinical concordance matter; a rare variant alone is not diagnostic, especially for alleles with uncertain or negative functional results.
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Clinical trio exome sequencing (GeneDx, Gaithersburg, MD) identified a maternally inherited variant in POLR1A c.1178G>A; p.(Arg393His)
    explanation: Trio sequencing identified an inherited variant classified as uncertain; clinical interpretation is necessary.
- name: Brain MRI for neurological or structural indications
  diagnosis_term:
    preferred_term: Magnetic Resonance Imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  description: MRI was used to assess neurological and structural findings in individual cases, including neonatal ischemia and syringomyelia. Normal studies were also reported. These observations do not establish universal screening intervals.
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Brain MRI at six days of life demonstrated right parietal ischemia
    explanation: MRI was used to assess neurological and structural findings in individual cases, including neonatal ischemia and syringomyelia. Normal studies were also reported. These observations do not establish universal screening intervals.
- name: Echocardiographic assessment
  diagnosis_term:
    preferred_term: Echocardiography Test
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  description: Echocardiography characterized cardiac anatomy in selected patients and was normal in others. The observations support phenotype-directed evaluation, not a quantified screening yield.
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Echocardiogram demonstrated anomalous origin of the right coronary
    explanation: Echocardiography characterized cardiac anatomy in selected patients and was normal in others. The observations support phenotype-directed evaluation, not a quantified screening yield.
- name: Polysomnography for suspected sleep-disordered breathing
  diagnosis_term:
    preferred_term: Polysomnography
    term:
      id: NCIT:C114185
      label: Polysomnography
  description: Polysomnography identified mixed obstructive and central apnea in one child. Testing is guided by symptoms and anatomy rather than a syndrome-specific schedule.
  evidence:
  - reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    reference_title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: As an infant, he had a polysomnography study which identified mixed obstructive and central apnea, treated with supplemental oxygen.
    explanation: Polysomnography identified mixed obstructive and central apnea in one child. Testing is guided by symptoms and anatomy rather than a syndrome-specific schedule.
discussions:
- discussion_id: polr1a_allelic_heterogeneity
  prompt: How do allele-specific transcription changes relate to clinical severity?
  notes: The 2023 cell assay separates reduced, increased and unchanged transcription. Neither direction alone explains the clinical spectrum. The p.Met496Ile structural modeling in 2025 is computational and does not override the measured mild increase in the 2023 assay. The 2020 p.Glu593Gln experiment supports a dominant-negative mechanism under inducible expression, not a universal mechanism for all variants.
  evidence:
  - *id005
  - *id006
  - reference: PMID:41010008
    reference_title: 'RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.'
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Structural modeling of the Met496Ile variant suggested disruption of DNA binding and polymerase activity
    explanation: The proposed interaction defect is computational; no direct activity experiment was performed in this report.
- discussion_id: polr1a_limb_mechanism
  prompt: What explains the limb abnormalities?
  notes: The developmental neural crest findings explain a craniofacial route. Limb skeletal abnormalities require a separate mechanism that remains unresolved; they are not modeled as a direct consequence of cranial neural crest depletion.
  evidence:
  - reference: PMID:25913037
    reference_title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    directness: DIRECT
    snippet: The specific mechanism underpinning femoral bowing, metaphyseal flaring, and delayed epiphyseal ossification in individual 1A1 is not yet understood.
    explanation: The founding paper explicitly leaves the limb mechanism unresolved.
- discussion_id: polr1a_later_development
  prompt: Does later Polr1a loss cause a distinct developmental defect?
  notes: Temporal ubiquitous knockout supports a later requirement for skeletal development, but its cell-state proportions and morphology do not discriminate fate selection from altered survival or proliferation. Separate NHP2 and TSR3 perturbations in engineered iPSCs and mice are not proven mediators of human POLR1A disease. The 2026 correction concerned author names and did not alter experimental results.
  evidence: *id007
- discussion_id: polr1a_cohort_attribution
  prompt: Which features are attributable to POLR1A in the expanded cohort?
  notes: The 2023 series includes related individuals and uncertain variants. Individual 13 also carries a de novo ATP1A1 variant; p.Pro1638Leu in individual 18 lacks supporting transcription or mouse phenotypes. Cohort counts therefore describe the reported series rather than confirmed feature frequencies. Craniosynostosis and hearing impairment are documented and are not valid exclusion criteria.
  evidence:
  - reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    reference_title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Individ- uals were included if they had a heterozygous variant in POLR1A interpreted as being of uncertain signiﬁcance, likely pathogenic, or pathogenic
    explanation: Ascertainment explicitly included variants of uncertain significance.
  - reference: PMID:41010008
    reference_title: 'RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Furthermore, our patient was reported, unbeknownst to us, with limited clinical, genetic, and protein data or analysis by Smallwood et al.
    explanation: The 2025 report explicitly identifies its overlap with individual 8 of the 2023 cohort.
references:
- reference: PMID:25913037
  title: Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.
- reference: url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211
  title: https://push-zb.helmholtz-munich.de/deliver.php?id=40211
- reference: PMID:33055158
  title: Transcriptional suppression of ribosomal DNA with phase separation.
- reference: PMID:41803115
  title: Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.
- reference: PMID:29750247
  title: tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.
- reference: PMID:35881792
  title: Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.
- reference: url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
  title: https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf
- reference: PMID:41010008
  title: 'RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.'
- reference: PMID:37075751
  title: POLR1A variants underlie phenotypic heterogeneity in craniofacial, neural, and cardiac anomalies.

📚

References & Deep Research

References

PMID:25913037

Acrofacial Dysostosis, Cincinnati Type, a Mandibulofacial Dysostosis Syndrome with Limb Anomalies, Is Caused by POLR1A Dysfunction.

No top-level findings curated for this source.

url:https://push-zb.helmholtz-munich.de/deliver.php?id=40211

https://push-zb.helmholtz-munich.de/deliver.php?id=40211

No top-level findings curated for this source.

PMID:33055158

Transcriptional suppression of ribosomal DNA with phase separation.

No top-level findings curated for this source.

PMID:41803115

Ribosomal modifications are associated with mesenchymal fate selection in the neural crest lineage.

No top-level findings curated for this source.

PMID:29750247

tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.

No top-level findings curated for this source.

PMID:35881792

Dynamic regulation and requirement for ribosomal RNA transcription during mammalian development.

No top-level findings curated for this source.

url:https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf

https://ars.els-cdn.com/content/image/1-s2.0-S0002929723000988-mmc1.pdf

No top-level findings curated for this source.

PMID:41010008

RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.

No top-level findings curated for this source.

PMID:37075751

POLR1A variants underlie phenotypic heterogeneity in craniofacial, neural, and cardiac anomalies.

No top-level findings curated for this source.

Deep Research

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Review POLR1A clinical spectrum and allele-specific developmental mechanisms · 2026-09-21T05:53:02Z · View source

Read the matching deep-research report and primary clinical, cellular and developmental sources, including the recovered 2015 article, 2023 full cohort and supplement, the 2020 dominant-negative experiment and 2026 temporal knockout study. Corrected false absence of craniosynostosis and hearing impairment, removed uniform reduced-function and de novo assumptions, and distinguished related/uncertain cases and repeat publication. Expanded specific clinical findings and documented care, separated 14 molecular/developmental nodes, and rebuilt six animal plus three cell-model records with assay, dosage, timing and negative-result limits. Independent peers audited the fish p53 experiment and temporal mouse model, followed by an integrated mechanism review. References were generated through the sanctioned fetcher using the tracked PMC adapter; no reference cache was hand-edited.

Create: Acrofacial Dysostosis Cincinnati Type (MONDO:0014651, POLR1A) · 2026-09-02T08:30:35Z · View source

De-novo curation of acrofacial dysostosis Cincinnati type (MONDO:0014651), the POLR1A Pol I ribosomopathy. Deep research: one openscientist run (research/Acrofacial_Dysostosis_Cincinnati_Type-deep-research-openscientist.md, 12/12 citations resolved, confabulation_rate 0.0). just preflight-dr PASSed against MONDO:0014651 with POLR1A mentioned 39 times; it flagged TP53 as a rival gene at 31% of POLR1A mentions, which is expected here since p53 is the effector arm of the mechanism rather than a second disease entity, and the sections were read with that in mind. Mechanism curated as two hypothesis groups. The canonical group runs from heterozygous POLR1A variants through reduced 47S rRNA transcription, the tissue-selective vulnerability of neuroepithelium and neural crest, RPL5/RPL11 sequestration of MDM2, and p53-dependent apoptosis, to depletion of neural-crest-derived skeletal precursors. A second EMERGING group holds the p53-independent arm, which exists because genetic tp53 inhibition in polr1a-mutant zebrafish suppresses the apoptosis and only partially rescues cartilage, leaving rDNA transcription and neural crest proliferation impaired. Three animal models are curated with distinct roles: the zebrafish mutant (including a RESCUES link for the tp53 inhibition experiment), lineage-restricted mouse conditional knockouts establishing cell-autonomy in three lineages, and CRISPR knock-in of two human alleles. Deliberate omissions, recorded in the entry notes. No phenotype carries a frequency. The deep-research report supplies an HPO-annotation-derived frequency table with denominators (hypotonia 10/17, hypertelorism 9/16, micrognathia 9/21, and so on, with craniosynostosis 0/15), but those are counts over annotation records rather than statements in either primary paper, so no cached sentence could evidence them. The table and its source are recorded in the entry notes for a curator who later obtains the per-individual tables. Three craniofacial phenotypes (micrognathia, malar hypoplasia, cleft palate) are graded directness: INDIRECT because their only quotable source describes this disease and Treacher Collins syndrome jointly. Validation: just validate-disorders, validate-terms, check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms, check-enum-values all pass. 38/38 snippets verified against cached references.

OpenScientist ▸

1. Disease Information

openscientist-autonomous 11 citations 2026-09-02T08:16:58.721165

1. Disease Information

Overview. AFDCIN is a rare Mendelian craniofacial dysostosis first delineated by Weaver and colleagues at Cincinnati Children's Hospital (hence "Cincinnati type"). "Acrofacial dysostosis" denotes a group of disorders combining facial dysostosis (mandibulofacial/otomandibular malformation) with limb (acral) anomalies. AFDCIN is distinguished within this group by its molecular cause: heterozygous POLR1A dysfunction (PMID: 25913037).

Key identifiers.

Resource	Identifier
OMIM (phenotype)	#616462
OMIM (gene POLR1A)	*616404
MONDO	MONDO:0014651
Orphanet	ORPHA:457395
Gene (HGNC)	HGNC:9082 (POLR1A)
NCBI Gene	25885
MANE transcript	NM_015425.6
Ensembl gene	ENSG00000068654
ICD-10	Q87.0 (congenital malformation syndromes predominantly affecting facial appearance) — no AFDCIN-specific code
ICD-11	LD2F.1Y (other specified developmental anomalies of face/neck) — no specific code

Synonyms / alternative names. Acrofacial dysostosis, Cincinnati type; AFDCIN; POLR1A-related acrofacial dysostosis; Cincinnati-type mandibulofacial dysostosis. Within the broader literature it is increasingly grouped with Pol I–related ribosomopathies alongside Treacher Collins syndrome types 2–4 (PMID: 41010008).

Source of information. All data are derived from aggregated disease-level resources and published case series (n < 25 total reported individuals) plus model-organism and in vitro studies — not from large EHR/registry populations. The disease is too rare for population EHR analysis.

2. Etiology

Primary cause — genetic. AFDCIN is a monogenic disorder caused by heterozygous pathogenic variants in POLR1A. Each of the three originally described individuals carried a heterozygous POLR1A mutation (PMID: 25913037: "Each individual has a heterozygous mutation in POLR1A, which encodes a core component of RNA polymerase 1."). The cohort was later expanded to 20 individuals with ≥13 unique heterozygous variants (PMID: 37075751).

Genetic risk factors. The causal variant itself is the risk factor; there are no established modifier loci or susceptibility alleles. Because most cases are de novo, the principal "risk factor" for a new case is a spontaneous germline mutation event. Advanced parental age is a plausible but unproven contributor to de novo mutation rate (general principle, not disease-specific).

Environmental risk factors. None identified. AFDCIN is a purely genetic Mendelian disorder; there is no evidence for toxic, infectious, nutritional, or lifestyle contributions to its occurrence.

Protective factors. No genetic or environmental protective factors are documented in humans. In animal models, genetic inhibition of tp53 suppresses neuroepithelial apoptosis and partially ameliorates the cranioskeletal phenotype — a "protective" mechanism at the pathway level, not a naturally occurring protective allele (PMID: 29750247).

Gene–environment interactions. None described. Given the fully genetic etiology and severe developmental phenotype, gene–environment interaction is not a feature of this disease.

3. Phenotypes

AFDCIN produces a multi-system phenotype dominated by craniofacial malformation, with neurodevelopmental, cardiac, growth, airway, and limb involvement. Phenotype frequencies below are drawn from authoritative HPO annotations (ontology.jax.org; primary sources PMID: 25913037 and PMID: 37075751) tallied across the reported cohort.

Phenotype	HPO term	Frequency (cohort)	Type
Congenital onset	HP:0003577	15/20 (75%)	Onset
Hypotonia	HP:0001252	10/17 (59%)	Neurological sign
Hypertelorism	HP:0000316	9/16 (56%)	Craniofacial sign
Global developmental delay	HP:0001263	8/14 (57%)	Neurodevelopmental
Micrognathia	HP:0000347	9/21 (43%)	Craniofacial sign
Microcephaly	HP:0000252	6/16 (38%)	Craniofacial/growth
Abnormality of limbs	HP:0040064	6/17 (35%)	Skeletal (acral)
Cleft palate	HP:0000175	6/20 (30%)	Craniofacial
Low-set ears	HP:0000369	6/17 (~35%)	Craniofacial
Microtia	HP:0008551	5/21 (24%)	Craniofacial
Ptosis	HP:0000508	5/18 (~28%)	Ocular/facial
Seizure	HP:0001250	5/5 (subset)	Neurological
Patent foramen ovale	HP:0001655	4/14 (29%)	Cardiac
Ventricular septal defect	HP:0001629 / HP:0001643	3/14 (21%)	Cardiac
Facial asymmetry	HP:0000324	3/18 (17%)	Craniofacial
Metopic synostosis	HP:0011330	3/18 (17%)	Craniofacial
Cleft lip	HP:0410030	2/17 (12%)	Craniofacial

Explicitly ABSENT features (important for differential diagnosis): Craniosynostosis HP:0001363 (0/15) and Macrocephaly HP:0000256 (0/13).

Craniofacial core. The facial gestalt is Treacher Collins–reminiscent: malar (zygomatic) and mandibular hypoplasia, micrognathia, downslanting palpebral fissures, external-ear anomalies (microtia, low-set ears), and cleft palate (PMID: 37075751).

Limb (acral) anomalies. Present in ~35% and variable; their presence with facial dysostosis defines the "acrofacial" designation. In the original series, 2/3 individuals had limb anomalies (PMID: 25913037).

Newly recognized systems (2023 expansion). Neurodevelopmental abnormalities and structural cardiac defects were added to the spectrum (PMID: 37075751: "observed numerous additional phenotypes including neurodevelopmental abnormalities and structural cardiac defects, in combination with highly prevalent craniofacial anomalies and variable limb defects.").

Characteristics. Onset is congenital (75% congenital onset). Severity is variable — from milder mandibulofacial dysostosis to severe multi-system disease. The malformations are structural and non-progressive (stable after birth), though secondary complications (airway obstruction, feeding difficulty) evolve over infancy. Variable expressivity is attributed in part to variant-specific molecular effects (PMID: 37075751: "In vitro assessments demonstrate variable effects of individual pathogenic variants on ribosomal RNA synthesis and nucleolar morphology, which supports the possibility of variant-specific phenotypic effects in affected individuals.").

Quality-of-life impact. No formal QoL instrument (EQ-5D, SF-36, PROMIS) data exist for this ultra-rare disease. Anticipated impacts, by analogy to mandibulofacial dysostoses: neonatal airway compromise and feeding difficulty (micrognathia, cleft palate), hearing loss (ear anomalies), speech impairment, neurodevelopmental disability, and psychosocial impact of facial difference. These require lifelong multidisciplinary support.

4. Genetic / Molecular Information

Causal gene. POLR1A (HGNC:9082; NCBIGene:25885; OMIM 616404), located at chromosome 2p11.2 (GRCh38 chr2:86,020,216–86,106,155). POLR1A encodes the largest catalytic subunit of RNA Polymerase I, the enzyme dedicated to transcribing the 47S ribosomal RNA precursor (PMID: 37075751: "Heterozygous pathogenic variants in POLR1A, which encodes the largest subunit of RNA Polymerase I, were previously identified as the cause of acrofacial dysostosis, Cincinnati-type."*).

Pathogenic variant spectrum (MANE NM_015425.6). ClinVar lists ~63 pathogenic/likely-pathogenic POLR1A records. Representative small variants:

Class	Example variant	Protein	ClinVar significance
Missense	c.928C>T	p.(Arg310Cys)	Likely pathogenic
Missense	c.2357C>T	p.(Thr786Ile)	Pathogenic
Missense	c.4685G>T	p.(Cys1562Phe)	Likely pathogenic
Nonsense	c.2164C>T	p.(Arg722Ter)	Likely pathogenic
Nonsense	c.2527C>T	p.(Arg843Ter)	Pathogenic
Nonsense	c.4297G>T	p.(Glu1433Ter)	Likely pathogenic
Frameshift	c.6del	p.(Ile3fs)	P/LP
Frameshift	c.190del	p.(Cys64fs)	P/LP
Frameshift	c.2374dup	p.(Tyr792fs)	P/LP
Frameshift	c.2267_2288del	p.(Ser756fs)	P/LP
Frameshift	c.3649del	p.(Gln1217fs)	P/LP
Missense (modeled)	Met496Ile	p.(Met496Ile)	disrupts DNA binding/polymerase activity (PMID: 41010008)

Structural variants. Large 2p11.2 CNVs (contiguous-gene deletions/duplications encompassing POLR1A) are also reported, consistent with a haploinsufficiency contribution.

Variant classification. Per ACMG/AMP, disease alleles are classified pathogenic or likely pathogenic; many additional missense alleles remain VUS, reflecting the challenge of interpreting missense change in a large essential subunit.

Allele frequency. Disease alleles are absent or ultra-rare in gnomAD (de novo, embryonic-lethal-adjacent). POLR1A itself is broadly conserved and highly expressed.

Functional consequences — dual mechanism. Two lines of evidence indicate that both dominant missense effects and haploinsufficiency operate:

Constraint. gnomAD constraint for POLR1A: missense Z = 5.08 (strong missense intolerance; oe_mis = 0.75), LoF LOEUF ≈ 0.49 (oe_lof = 0.41), pLI = 0.22, lof_z = 7.18. Thus POLR1A is highly intolerant of missense change and only moderately tolerant of loss of function — a pattern favoring missense/dominant-negative pathogenesis while not excluding LoF.
Mutational spectrum. The co-occurrence of missense, truncating (nonsense/frameshift) LoF, and whole-gene CNV pathogenic alleles indicates that haploinsufficiency also contributes (PMID: 37075751).

Structural modeling of the p.Met496Ile variant suggested disruption of DNA binding and polymerase activity, mechanistically linking a specific missense change to reduced Pol I catalytic function (PMID: 41010008).

Modifier genes. None established. Phenotypic heterogeneity is attributed primarily to variant-specific effects rather than trans-acting modifiers.

Epigenetic information / chromosomal abnormalities. No disease-specific methylation signature is described. Chromosomal-level lesions relevant to AFDCIN are the 2p11.2 CNVs noted above.

5. Environmental Information

Not applicable. AFDCIN is a monogenic developmental disorder with no known environmental, lifestyle, toxic, or infectious contributors. No teratogen, occupational exposure, dietary factor, or pathogen is implicated in its causation or triggering.

6. Mechanism / Pathophysiology

Ordered causal chain

A heterozygous POLR1A variant (missense, truncating LoF, or whole-gene CNV) reduces the function or dosage of the largest catalytic subunit of RNA Polymerase I.
Reduced Pol I activity leads to deficient transcription of 47S pre-ribosomal RNA (the rate-limiting step of ribosome biogenesis) — demonstrated in polr1a zebrafish.
Deficient rRNA transcription results in reduced ribosome (monosome/polysome) assembly and impaired protein translation — demonstrated.
Impaired ribosome biogenesis causes nucleolar stress, which results in stabilization/activation of TP53 — demonstrated in Pol I ribosomopathy models.
TP53 activation leads to apoptosis of neuroepithelial progenitor cells — demonstrated (Tp53-dependent neuroepithelial apoptosis).
Neuroepithelial apoptosis results in a deficiency of migrating cranial neural crest cells (NCCs) — the progenitors of most craniofacial skeletal structures — demonstrated.
Reduced NCC number and proliferation leads to hypoplasia of NCC-derived craniofacial skeleton → mandibulofacial dysostosis (malar/mandibular hypoplasia, micrognathia, ear/palate defects).
Branch A (cranial): the same neuroepithelial vulnerability contributes to neurodevelopmental phenotypes (hypotonia, developmental delay, microcephaly, seizures) — inferred.
Branch B (cardiac/limb): NCC and mesodermal contributions to cardiac outflow and limb development contribute to structural cardiac and limb anomalies — inferred.
Tissue selectivity arises because NCC progenitors sustain unusually high rRNA transcription and translation, rendering them particularly sensitive to rRNA synthesis defects — demonstrated (PMID: 35881792: "High expression of Pol I subunits sustains elevated rRNA transcription in NCC progenitors, which supports their high tissue-specific levels of protein translation, but also makes NCCs particularly sensitive to rRNA synthesis defects.").

POLR1A variant (missense / LoF / CNV)
│  ↓ Pol I catalytic function / dosage
▼
↓ 47S pre-rRNA transcription  ──────────────►  [rate-limiting step]
│
▼
↓ ribosome biogenesis / translation
│
▼
Nucleolar stress ──► TP53 stabilization/activation
│
▼
Neuroepithelial apoptosis (TP53-dependent)
│
▼
Cranial neural crest cell deficiency  ◄── high tissue-specific
│                                  translation demand
├──► craniofacial skeletal hypoplasia → mandibulofacial dysostosis
├──► (inferred) neurodevelopmental anomalies
└──► (inferred) cardiac / limb anomalies

Detail by category

Molecular pathways: RNA Polymerase I–dependent rDNA/rRNA transcription and ribosome biogenesis; downstream TP53 (p53) tumor-suppressor / nucleolar stress response signaling. Convergence on nucleolar organization and ribosomal RNA transcription was confirmed by network analyses (STRING, Pathway Commons) placing POLR1A among Pol I / ribosome-biogenesis partners (PMID: 41010008).
Cellular processes: Apoptosis (TP53-dependent) of neuroepithelial cells; reduced cell proliferation of neural crest progenitors; a DNA-damage/nucleolar-stress response (related Pol I disorders show rDNA damage and DNA-damage response, PMID: 29364875).
Protein dysfunction: Missense variants can act as loss-of-function or dominant-negative within the Pol I holoenzyme (e.g., p.Met496Ile disrupts DNA binding/polymerase activity); truncating variants and CNVs reduce dosage (haploinsufficiency).
Metabolic changes: Reduced translational capacity in high-demand progenitors; no specific small-molecule metabolic defect.
Immune involvement: None; not an immune-mediated disease.
Tissue damage mechanism: Nucleolar stress → apoptosis of specific progenitor pools; the injury is developmental (failure to form structures) rather than degenerative.
Epigenetic changes: Not specifically implicated; the lesion is at the level of Pol I transcription of rDNA.
Molecular profiling: Zebrafish polr1a mutants show reduced 47S rRNA, reduced monosomes/polysomes, and impaired translation (PMID: 25913037; PMID: 29750247: "This results in Tp53-dependent neuroepithelial apoptosis, diminished neural crest cell proliferation and cranioskeletal anomalies."). In vitro patient-variant assays show variable effects on rRNA synthesis and nucleolar morphology (PMID: 37075751).

Suggested ontology terms. GO biological process: rRNA transcription (GO:0009303), transcription by RNA polymerase I (GO:0006360), ribosome biogenesis (GO:0042254), regulation of apoptotic process (GO:0042981), neural crest cell migration (GO:0001755), neural crest cell development (GO:0014033). GO cellular component: nucleolus (GO:0005730), RNA polymerase I complex (GO:0005736). CL cell types: neural crest cell (CL:0000333), neuroepithelial cell (CL:0000710).

7. Anatomical Structures Affected

Organ / system level. - Primary: craniofacial skeleton and soft tissues — zygoma/malar (UBERON:0001683 zygomatic bone), mandible (UBERON:0001684), maxilla (UBERON:0002397), palate (UBERON:0001716), external ear/auricle (UBERON:0001757). - Nervous system (UBERON:0001016): brain/neuroepithelium — hypotonia, developmental delay, microcephaly, seizures. - Cardiovascular system (UBERON:0004535): heart — VSD, patent foramen ovale. - Musculoskeletal / limbs (UBERON:0002101): variable acral anomalies. - Respiratory / upper airway: secondary obstruction from micrognathia/palatal cleft.

Tissue / cell level. The critical target is the cranial neural crest cell (CL:0000333) and the neuroepithelium (CL:0000710) from which affected NCCs derive. Downstream, cartilage/bone (skeletal connective tissue) of the face is hypoplastic.

Subcellular level. The initiating compartment is the nucleolus (GO:0005730), site of Pol I–driven rRNA transcription; the effector pathway involves the nucleus (TP53) and the cytoplasmic translational machinery (ribosomes, GO:0005840).

Localization / lateralization. Craniofacial involvement is typically bilateral, though facial asymmetry (HP:0000324) occurs in ~17%. Limb involvement is variable and can be asymmetric.

8. Temporal Development

Onset: Congenital — malformations are established during embryonic craniofacial development; 75% of the cohort had documented congenital onset (HP:0003577). Onset pattern is structural/developmental, not acute.
Progression: The primary malformations are stable/non-progressive after birth. There are no "stages." Secondary sequelae evolve over infancy and childhood — airway obstruction and feeding difficulty are most critical in the neonatal period; hearing, speech, and developmental trajectories unfold thereafter.
Course: Chronic, lifelong structural condition managed by staged reconstruction and developmental support.
Critical periods: The embryonic window of neural crest specification, proliferation, and migration is the vulnerable/opportunity window — the point at which the ribosome-biogenesis deficit exerts its damage. In animal models, TP53-pathway inhibition during this window partially prevents the phenotype (PMID: 29750247), but no equivalent human intervention exists.
Remission: Not applicable — structural malformation does not remit; surgical correction is the only means of anatomical improvement.

9. Inheritance and Population

Epidemiology: Ultra-rare. Fewer than ~25 individuals reported worldwide (3 in 2015; expanded to 20 in 2023). No reliable prevalence/incidence estimate exists; Orphanet classifies it among ultra-rare craniofacial disorders (ORPHA:457395).
Inheritance pattern: Autosomal dominant. Most cases are de novo (spontaneous), consistent with reduced reproductive fitness of severely affected individuals.
Penetrance: Presumed high/complete for the malformation phenotype among carriers of established pathogenic variants; formal penetrance estimates are unavailable given small numbers.
Expressivity: Variable, attributed to variant-specific molecular effects on rRNA synthesis and nucleolar morphology (PMID: 37075751).
Genetic anticipation: Not applicable (not a repeat-expansion disorder).
Germline mosaicism: Not specifically documented but theoretically possible; relevant to recurrence-risk counseling for apparently de novo cases.
Founder effects / consanguinity: None (dominant, de novo; consanguinity is not a risk factor).
Carrier frequency: Not applicable (dominant, not carrier-based).
Population demographics: No ethnic predilection; cases reported across populations. Sex ratio appears roughly equal (no strong sex bias reported). Age distribution: diagnosed in infancy/childhood given congenital malformation.

10. Diagnostics

Diagnostic approach. Diagnosis rests on clinical recognition of Treacher Collins–like mandibulofacial dysostosis (with/without limb anomalies) followed by molecular confirmation of a heterozygous pathogenic POLR1A variant.

Genetic testing (the definitive test). - Exome sequencing (WES) or a craniofacial/mandibulofacial dysostosis gene panel including POLR1A is the highest-yield approach; the original discovery used exome sequencing (PMID: 25913037). - Single-gene POLR1A sequencing (MANE NM_015425.6) is appropriate when the phenotype is characteristic. - Chromosomal microarray (CMA) detects 2p11.2 CNVs involving POLR1A. - Genome sequencing (WGS) can capture both SNVs and structural variants in one assay. - Related genes to include on a differential panel: TCOF1, POLR1C, POLR1D, POLR1B (Treacher Collins types 1–4), EFTUD2, SF3B4 (other acrofacial dysostoses).

Clinical / imaging tests. Craniofacial CT/X-ray documents malar and mandibular hypoplasia; echocardiography screens for cardiac defects; audiology assesses hearing; airway evaluation (endoscopy/polysomnography) assesses obstruction; brain MRI and developmental assessment characterize neurodevelopmental involvement. No specific biomarker or laboratory abnormality is diagnostic.

Clinical criteria. No formal consensus diagnostic criteria exist; diagnosis is gestalt-based plus molecular confirmation.

Differential diagnosis. Chief differentials — Treacher Collins syndrome (types 1–4; TCOF1/POLR1C/POLR1D/POLR1B), mandibulofacial dysostosis with microcephaly (EFTUD2), Nager acrofacial dysostosis (SF3B4), oculoauriculovertebral spectrum/Goldenhar. Distinguishing features favoring AFDCIN: the specific POLR1A genotype, and the absence of craniosynostosis and macrocephaly (both 0/cohort). Notably, AFDCIN overlaps clinically and mechanistically with Sweeney-Cox, Saethre-Chotzen, Robinow-Sorauf, and TCS types 2–4, all now proposed as part of a Pol I–related ribosomopathy spectrum (PMID: 41010008).

Screening. No newborn or carrier screening exists. Cascade testing of parents is used mainly to establish de novo status and recurrence risk.

11. Outcome / Prognosis

Survival / mortality: No formal survival statistics. Prognosis is driven by severity of airway compromise and associated anomalies (cardiac, CNS). Severe neonatal airway obstruction and feeding failure are the principal early-life threats; with modern multidisciplinary craniofacial care many affected individuals survive into childhood and beyond.
Morbidity / function: Substantial. Long-term morbidity includes hearing loss, speech impairment, feeding/airway issues, facial difference, and neurodevelopmental disability (hypotonia 59%, developmental delay 57%, seizures in a subset).
Disease course: Chronic and stable structurally; complications (recurrent otitis/hearing loss, obstructive sleep apnea, dental/orthognathic issues) accrue over time.
Recovery potential: The malformations do not spontaneously resolve but are partially correctable surgically. Neurodevelopmental outcome depends on the degree of CNS involvement.
Prognostic factors: Extent of airway obstruction, presence/severity of cardiac and CNS anomalies, and — molecularly — the variant-specific effect on Pol I function, which correlates with phenotypic severity (PMID: 37075751).
Quality-of-life instruments: No disease-specific QoL data available.

12. Treatment

No disease-modifying or targeted therapy exists. Management is supportive, symptom-directed, and multidisciplinary, coordinated through a craniofacial team.

Supportive / surgical mainstays. - Airway management: positioning, nasopharyngeal airway, mandibular distraction osteogenesis, or tracheostomy for severe micrognathia-related obstruction. A non-surgical intra-oral orthopaedic appliance has been reported to relieve upper-airway obstruction in related mandibular micrognathia/craniofacial anomalies and may be applicable (PMID: 9633164). - Feeding support: specialized feeding, NG/gastrostomy as needed. - Cleft palate repair and staged craniofacial/orthognathic reconstruction (NCIT: Reconstructive Surgery). - Hearing / ear: audiologic management, bone-conduction/hearing aids, otologic/reconstructive surgery for microtia. - Cardiac: management/repair of structural defects as indicated. - Neurodevelopmental: early intervention, physical/occupational/speech therapy; seizure management.

Pharmacotherapy / pharmacogenomics / advanced therapeutics. No approved pharmacologic, gene, cell, or RNA-based therapy. Pathway-level proof of concept exists only in animal models: genetic inhibition of tp53 suppresses neuroepithelial apoptosis and partially ameliorates the cranioskeletal phenotype, but does not restore rDNA transcription or NCC proliferation (PMID: 29750247) — a conceptual, embryonic-window intervention with no human translation.

Experimental / trials. No AFDCIN-specific clinical trials (NCT) identified. Given ultra-rarity, care follows general craniofacial-anomaly best practice rather than disease-specific protocols.

Suggested NCIT terms: Reconstructive Surgery (C15329), Supportive Care (C15277), Physical Therapy (C15367), Speech Therapy (C15451), Tracheostomy (C51844).

13. Prevention

Primary prevention: Not possible — the disease arises from spontaneous de novo mutation. No modifiable risk factor exists.
Secondary prevention: Prenatal detection — characteristic mandibulofacial anomalies may be identified on prenatal ultrasound; prenatal molecular testing is possible when a familial variant is known.
Tertiary prevention: Early multidisciplinary intervention to prevent complications (airway monitoring/sleep studies, hearing surveillance, developmental support) is the principal preventive strategy.
Genetic counseling: Central to management. For a de novo case, recurrence risk to parents is low but nonzero (germline mosaicism); an affected individual has a 50% transmission risk (autosomal dominant). Preimplantation genetic testing and prenatal diagnosis are options when the variant is known.
Immunization / public-health / environmental interventions: Not applicable.

14. Other Species / Natural Disease

Model species with disease relevance: Zebrafish (Danio rerio, NCBI Taxon 7955) polr1a mutants recapitulate the core mechanism and cranioskeletal phenotype (PMID: 25913037; PMID: 29750247). Related Pol I subunit models (polr1c, polr1d) reproduce Treacher Collins–like anomalies (PMID: 27448281).
Orthologous genes: Polr1a in mouse (Mus musculus, Taxon 10090) and zebrafish; the gene and Pol I function are deeply evolutionarily conserved across eukaryotes.
Naturally occurring disease in animals: No naturally occurring POLR1A-related acrofacial dysostosis is documented in companion animals or wildlife (no OMIA entry noted). The disease is known only through humans and engineered/mutant models.
Comparative biology: The NCC-selective vulnerability to nucleolar stress is conserved across zebrafish, Xenopus, mouse, and human, making cross-species comparison highly informative (PMID: 25756904; PMID: 24497835).
Zoonotic potential: None (genetic disease).

15. Model Organisms

Model	Type	Genetic manipulation	Phenotype recapitulation	Reference
Zebrafish polr1a mutant	Vertebrate	Loss-of-function	Deficient 47S rRNA transcription, ↓ monosomes/polysomes, Tp53-dependent neuroepithelial apoptosis, ↓ NCC proliferation, cranioskeletal anomalies mimicking human disease	PMID: 25913037; PMID: 29750247
Zebrafish polr1c / polr1d mutants	Vertebrate	Homozygous LoF	Cartilage hypoplasia, TCS-like cranioskeletal defects; tp53 inhibition ameliorates	PMID: 27448281
Xenopus nol11 knockdown	Vertebrate	Morpholino knockdown	Impaired pre-rRNA transcription/processing, apoptosis, abnormal craniofacial cartilage; p53 rescue	PMID: 25756904
Zebrafish wdr43 (fantome)	Vertebrate	Point mutation/premature stop	Ribosome biogenesis defect, p53-dependent NCC craniofacial cartilage defects	PMID: 24497835
Drosophila Nopp140 RNAi	Invertebrate	RNAi depletion	Nucleolar stress, ribosome loss, apoptosis (p53-independent in fly)	PMID: 23412656
Patient-variant in vitro assays	Cellular	Expression of individual POLR1A variants	Variable effects on rRNA synthesis and nucleolar morphology	PMID: 37075751

Phenotype recapitulation. The zebrafish polr1a model is the primary disease model and faithfully reproduces the mechanistic cascade and craniofacial output. Limitations: models capture craniofacial/NCC biology well but incompletely model the human neurodevelopmental and cardiac spectrum; the acral/limb component is not the focus of fish models; and Drosophila apoptosis is p53-independent, limiting mechanistic transfer.

Resources: ZFIN (zebrafish), MGI (mouse orthologue Polr1a), Xenbase (Xenopus), FlyBase (Drosophila).

Mechanistic Model / Interpretation

AFDCIN is best understood as a prototypical Pol I ribosomopathy that sits within a continuum of RNA Polymerase I–related craniofacial syndromes together with Treacher Collins types 2–4, Sweeney-Cox, Saethre-Chotzen, and Robinow-Sorauf (PMID: 41010008). The unifying logic is that a quantitative reduction in ribosome-building capacity — whether from a POLR1A missense change that cripples the catalytic subunit or from a truncating/CNV allele that halves its dosage — is tolerated by most cells but not by the metabolically extreme cranial neural crest, which must synthesize protein at very high rates to proliferate and migrate on schedule. When rRNA supply falls below this demand, nucleolar stress activates TP53, apoptosis prunes the neuroepithelial/NCC pool, and the craniofacial skeleton that those cells would have built is left hypoplastic. This elegantly resolves the central paradox of the ribosomopathies: how a housekeeping defect yields a tissue-specific malformation.

Two refinements distinguish this investigation's model. First, the mechanism is genotype-graded: individual variants exert variable effects on rRNA synthesis and nucleolar morphology, and this molecular gradient plausibly underlies the observed variable expressivity and the newly appreciated multi-system (neurodevelopmental, cardiac) breadth. Second, the mutational mechanism is dual. gnomAD constraint (mis_z = 5.08) marks POLR1A as exquisitely missense-intolerant — the signature of a subunit where a single altered residue can poison the holoenzyme (loss-of-function or dominant-negative) — yet the presence of bona fide truncating and whole-gene-deletion pathogenic alleles shows that haploinsufficiency also causes disease. The practical implication is that AFDCIN cannot be reduced to a single molecular class; variant interpretation must accommodate both mechanisms.

The TP53 node is the most therapeutically provocative element. Across zebrafish, Xenopus, and mouse models, genetic p53 inhibition rescues the apoptosis and partially the skeleton without correcting the upstream rRNA deficit — establishing p53 as a downstream, druggable effector but also warning that suppressing apoptosis leaves the fundamental ribosome shortfall unaddressed and carries oncogenic risk. Any future intervention would need to act within the narrow embryonic window of neural crest development, which is currently inaccessible in human patients.

Evidence Base

PMID	Title (abbrev.)	Contribution
25913037	AFDCIN is caused by POLR1A dysfunction	Founding paper: 3 individuals, heterozygous POLR1A; zebrafish model; establishes gene and dominant inheritance
37075751	POLR1A variants underlie phenotypic heterogeneity	Cohort expansion to 20; adds neurodevelopmental + cardiac phenotypes; variant-specific rRNA/nucleolar effects
29750247	tp53-dependent and independent signaling in AFDCIN	Defines causal chain: rRNA deficit → Tp53 neuroepithelial apoptosis → NCC deficiency → cranioskeletal anomalies; p53 inhibition as prevention
35881792	Requirement for rRNA transcription in development	Explains NCC tissue-selective vulnerability to rRNA synthesis defects
41010008	Pol I dysfunction underlying craniofacial syndromes	Positions AFDCIN within a Pol I ribosomopathy spectrum; structural modeling of p.Met496Ile
29364875	Tissue-selective nucleolar stress and rDNA damage	Nucleolar stress → rDNA damage → p53 apoptosis in cranial NCCs (mechanistic parallel)
27448281	Polr1c/Polr1d in craniofacial development	Companion Pol I subunit zebrafish models; tp53 rescue
25756904	Nol11 in Xenopus craniofacial development	Cross-species conservation; p53 rescues skeleton but not ribosome defect
24497835	Wdr43 in zebrafish development	Ribosome biogenesis → p53-dependent NCC craniofacial defects
23412656	Nucleolar stress in Drosophila (Nopp140)	Invertebrate nucleolar-stress model (p53-independent apoptosis)
34714179	Mandibulofacial dysostoses case series (India)	Context on phenotypic/molecular heterogeneity of mandibulofacial dysostoses
9633164	Non-surgical airway management	Supportive-care option for micrognathia-related airway obstruction

Evidence source types: human clinical case series (n < 25 total), model-organism studies (zebrafish/Xenopus/Drosophila), in vitro variant assays, and computational/constraint analyses (gnomAD, ClinVar, structural modeling). No randomized trials or large registries exist.

Limitations and Knowledge Gaps

Tiny evidence base. Fewer than ~25 individuals reported; frequencies (e.g., micrognathia 43%) rest on small denominators and are subject to ascertainment bias toward severe cases.
No epidemiologic data. Prevalence, incidence, penetrance, and survival are not formally quantified.
Genotype–phenotype correlation is incomplete. Although variant-specific in vitro effects are demonstrated, the mapping from specific POLR1A alleles to clinical severity and to the missense-vs-LoF mechanistic split remains only partially resolved; many missense alleles are VUS.
Human mechanism is inferential for non-craniofacial systems. The neurodevelopmental, cardiac, and limb branches of the causal chain are extrapolated from the craniofacial mechanism and model organisms, not directly demonstrated in human tissue.
No therapeutics. p53-pathway rescue is confined to embryonic animal models with no human translation and unresolved oncogenic-safety concerns.
No QoL / natural-history data and no standardized diagnostic criteria.

Proposed Follow-up Experiments / Actions

International patient registry & natural-history study to establish prevalence, penetrance, survival, and standardized phenotype frequencies with adequate denominators.
Systematic genotype–phenotype correlation pairing each POLR1A variant with quantitative rRNA-synthesis/nucleolar-morphology assays and detailed phenotyping to test the missense-severity vs LoF hypothesis and to reclassify VUS.
Functional reclassification pipeline (deep mutational scanning of POLR1A in a cellular Pol I–activity readout) to resolve the many missense VUS in ClinVar.
Conditional / graded mouse models (mammalian Polr1a allelic series) to model the neurodevelopmental and cardiac branches not captured in fish and to test dosage vs dominant-negative mechanisms.
Therapeutic window studies probing whether modulating nucleolar stress/p53 (or boosting ribosome biogenesis) during neural crest development can rescue the phenotype safely — using the established zebrafish and future mouse models.
Standardized diagnostic criteria and multidisciplinary care guideline for AFDCIN within the broader Pol I ribosomopathy spectrum, incorporating the absence of craniosynostosis/macrocephaly as discriminating features.

Report compiled from 7 confirmed findings and 12 reviewed papers across a 5-iteration autonomous investigation. Evidence is predominantly human case-series plus model-organism and computational data; no clinical-trial-level evidence exists for this ultra-rare disorder.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	12
Resolved	12
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	12
On topic	7
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	43
Resolved	40
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	3
Terms whose name was checked	22
Terms named correctly	18
Terms named as a different term	1
Terms whose name is worth a second look	3

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

MONDO:0014651 (2 mentions) - the report calls it "MONDO"; MONDO calls it acrofacial dysostosis Cincinnati type

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

CL:0000333 (2 mentions) - the report calls it "cranial neural crest cell"; CL calls it migratory neural crest cell
CL:0000710 (2 mentions) - the report calls it "neuroepithelium"; CL calls it neurecto-epithelial cell, and lists "neuroepithelial cell" among its other names
UBERON:0002101 (1 mention) - the report calls it "Musculoskeletal / limbs"; UBERON calls it limb

Terms named inconsistently

The report gives these identifiers more than one name of its own:

HP:0000324 - called "Facial asymmetry", "facial asymmetry"

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA, NCBIGene.

Ask OpenScientist

OpenScientist Report

Mappings

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic / Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

Ordered causal chain

Detail by category

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome / Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Mechanistic Model / Interpretation

Evidence Base

Limitations and Knowledge Gaps

Proposed Follow-up Experiments / Actions

Artifacts

Reference Validation

Term Validation

Terms the report names something else

Terms whose name is worth a second look

Terms named inconsistently

Prefixes with no resolver